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ABSTRACT
The Characterization, Functional Expression, and Localization of the First Arthropod
Myokinin Receptor from the Southern Cattle Tick, Boophilus microplus (Acari:
Ixodidae). (December 2003)
Steven P. Holmes, B.S., Brigham Young University;
M.S., Texas A&M University
Chair of Advisory Committee:  Dr. Patricia V. Pietrantonio
Myokinins are invertebrate neuropeptides with myotropic and diuretic activity.
The lymnokinin receptor from the snail Lymnaea stagnalis was the only previously
identified myokinin receptor.  A cDNA encoding a neuropeptide receptor was cloned
from the southern cattle tick, Boophilus microplus.  The deduced amino acid sequence
was 40 % identical to the lymnokinin receptor.  The receptor transcript is present in all
tick life stages as determined by semiquantitative RT-PCR.  When expressed in
mammalian CHO-K1 cells, myokinins at nanomolar concentrations induced increases in
intracellular calcium as measured by fluorescent cytometry.  The rank order of potency
for peptides tested was FFFSWS-NH2≥FFFSWG-NH2≥FFSWG-NH2>FYSWG-
NH2>muscakinin>lymnokinin>>APTGFFGVR-NH2.  The receptor coupled to a
pertussis toxin insensitive G protein.  Absence of extracellular calcium did not inhibit
the calcium response, indicating the release of Ca2+ from intracellular stores.  Receptor
transcript was detected by RT-PCR in the dissected synganglia, ovaries, salivary glands,
iv
guts and Malpighian tubules of partially engorged adult female ticks.  It is concluded
that the B. microplus receptor is the first myokinin receptor cloned from an arthropod,
and the first neuropeptide receptor known from the Acari.  The presence of this receptor
transcript in multiple tissues and all life stages suggests a multifunctional role in ticks.
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1CHAPTER I
INTRODUCTION 
Background
Overview and definition of G protein-coupled receptor (GPCR) superfamily
The fundamental ability of cells to interact and adjust to their environment is
accomplished primarily through cell surface receptors and channels that respond
specifically to a variety of compounds (Uings & Farrow, 2000).  G protein-coupled
receptors (GPCRs) are the largest single class of eukaryotic receptors (Iismaa et al.,
1995), and are the largest superfamily of proteins in the human body and constitute the
majority of receptors on the plasma membrane (Gether, 2000; Watson & Arkinstall,
1995).  Over one thousand GPCRs were known in 1998 (Vaughan, 1998) and additional
ones are characterized each year.  GPCRs consist of a single polypeptide chain and share
a seven transmembrane (TM) domain topology (Fig. 1), and are named based on their
ability to recruit and activate heterotrimeric G proteins, although they are not the only
receptors that can activate G proteins (Iismaa et al., 1995).
GPCRs vary significantly in overall length, although the length of primary
sequence comprising the transmembrane domains is fairly constant. The smallest known
GPCR, the human adrenocorticotropic receptor, is only 297 amino acid residues in
length while the metabotropic glutamate receptor mGluR1a is 1180 residues (Iismaa et
al., 1995).  There is no overall sequence homology that can be used to define the
                                                
  This dissertation follows the style and format of Insect Molecular Biology.
2superfamily of GPCRs, although there is significant similarity within some individual
subfamilies of GPCRs (Gether, 2000).  However, some subfamilies share surprisingly
little homology.  For example, among the three mammalian neuropeptide Y receptors,
subtypes Y1 and Y2 have only 31% overall sequence identity (Larhammar, 1996).  This
low homology and the relative low abundance of many GPCRs in tissues has made them
difficult to clone or to characterize by biochemical methods.  However the recent
completion of genome projects for several species, including the fruit fly Drosophila
melanogaster, and the malaria mosquito Anopheles gambiae have revealed genes for
many previously unknown GPCRs (Adams et al. 2000; Holt et al., 2002).  This new
wealth of genomic information will surely accelerate investigation and identification of
GPCR gene candidates, as already seen by the identification of over one hundred genes
encoding fora novel family of putative odorant receptors (Vosshall et al. 1999) and for
the drosokinin receptor (Radford et al., 2002).
The first GPCRs to be characterized were the rhodopsin receptor and the β-
adrenergic receptor (Hargrave & McDowell, 1992; Shorr et al., 1981).  Much of what is
known of GPCR structure is based on these two receptors.  The seven TM structure
common to GPCRs was predicted based on studies of rhodopsin, because this receptor is
available in high quantities and easily purified from rod cells (Hargrave & McDowell,
1992).   Low resolution electron crystallography structures of frog and bovine
rhodopsins, resolved down to 6  and 9.5 angstroms, respectively, revealed an asymmetric
clockwise arrangement of the TMs as viewed from the interior of the cell.  Helices 1-3
and 5 are tilted while 4, 6, 7 are nearly perpendicular (Schertler et al., 1993), (Schertler
3Figure 1.  The three major classes of GPCRs.  A diagram of a typical member of each
class is shown.  In Class A receptors, conserved features include a disulfide bridge
between Cys residues on extracellular loops 1 and 3, a DRY sequence on the 2nd
intracellular loop, and a palmitoylated Cys in the C-terminal tail.  Redrawn from Gether
(2000) by Balu Jegganathan.
4Figure 1. Continued.
5& Hargrave, 1995), (Unger & Schertler, 1995).  Recently, high resolution x-ray
diffraction of the 3D crystal structure of bovine rhodopsin in inactive conformation at
2.8 angstrom has confirmed the predicted seven transmembrane structure (Palczewski et
al., 2000).
GPCR diversity of function and ligands
GPCRs are the most common signal transduction system in animals (Bouvier,
2001).  Their endogenous ligands perform or mediate a wide range of functions,
including neurotransmission, cellular metabolism, secretion, cellular differentiation and
growth, and may act as neuropeptides, polypeptide hormones, and inflammatory
mediators.  These receptors respond to a variety of bioactive molecules, including
biogenic amines, peptides, glycoproteins, lipids, nucleotides, amino acids, and ions
(Gether, 2000; Iismaa et al., 1995; Bouvier, 2001).  An emerging family of GPCRs, the
protease-activated receptors, has also been discovered.  Following a specific proteolytic
cleavage of the N-terminus, the new N-terminal region interacts with other domains to
activate the receptor (Derian et al. 2002).  The majority of bioactive molecules,
hormones, and neurotransmitters transduce their signal through specific interactions with
GPCRs which activate cellular signal transduction mechanisms (Iismaa et al., 1995;
Gether & Kobilka, 1998).  GPCRs are the principal signal transducers for the sensation
of external stimuli such as light, odors, and taste (Gether & Kobilka, 1998), (Gether,
2000).
6Overview of signaling
GPCR signal transduction pathways classically consist of three elements: the
receptor, a heterotrimeric G protein (consisting of α, β, and γ subunits), and downstream
effector components.  Upon binding an external ligand, GPCRs transmit a signal to the
interior of the cell.  Ligand binding promotes allosteric interactions with a cytosolic G
protein.  The GPCR activates the heterotrimeric G protein, resulting in its dissociation
into separate monomeric α and heterodimeric βγ subunits, which modulate the effector
units in a signal transduction pathway that involves the release or production of other
second messengers (Bouvier, 2001).  Each receptor may activate a large number of G
proteins before the signal is terminated, allowing amplification of the external signal
(Uings & Farrow, 2000).  Upon ligand binding, GPCRs undergo a conformational
change that allows them to bind and activate a specific class of heterotrimeric G-
proteins.  Although the mechanisms effecting the conformational changes in the receptor
upon ligand binding are not well understood, certain key elements have been elucidated.
Current research suggests that activation changes the relative orientation or position of
several TM segments, which exposes previously inaccessible key residues on the
intracellular surface of the receptor critical for interacting with specific G proteins
(Wess, 1997).  Studies suggest that activation of rhodopsin involves a small outward
movement of TM III and a clockwise rotation of TM VI along with an outward
movement of the cytoplasmic end (Wess, 1997).
Upon activation, the G protein exchanges a bound molecule of GDP for GTP,
and dissociates into the activated α and βγ subunits.  The α subunit is known to activate
7downstream elements in a signal transduction pathway, including adenylate cyclase,
guanylate cyclase, phospholipase C, phospholipase A2, phosphodiesterases, and Ca2+
and K+ channels (Strader et al., 1989).  The role of the βγ subunit in cell signaling is
more complex and not as well understood as that of the α subunit.  In addition to direct
signaling it has also been shown to modulate signal transduction by receptor crosstalk.
Stimulation of the Gαi-coupled adenosine A1 and α2c-adrenergic receptors in
Cercopithecus Origin-deficient SV40 transformed (COS) cells leads to the enhancement
of inositol phosphate signaling from Gαq coupled receptors that is mediated by Gβγ
exchange (Quitterer & Lohse, 1999).
Classes of GPCRs
GPCRs have been classified into 3 major (A, B, C) and 3 minor (D, E, F)
classes or families.  Family A is the largest and consists of the receptors related to the
rhodopsin and β-adrenergic receptors, including most kinin receptors and the tick
myokinin receptor.  Family A receptors are commonly modeled based on the structure of
rhodopsin, which is intermediate in size among Family A and is considered typical of
this family.  Family A receptors have a disulfide bridge between cysteine residues in the
1st and 2nd extracellular loop, and the highly conserved DRY sequence (or similar, see
page 12) on the amino-terminal end of the 2nd intracellular loop (Fig. 1).  Family B is
made up of approximately 20 receptors related to the glucagon receptor, and includes
receptors for several peptide hormones (Gether, 2000).  Family B is characterized by a
long exracellular N-terminus of approximately 100 residues that contains several
8cysteines, which are assumed to form a network of disulfide bonds (Ulrich et al., 1998).
Family C consists of the metabotropic neurotransmitter receptors and related receptors,
such as the γ-aminobutyric acid (GABA) receptors, calcium receptors, and some
mammalian pheromone receptors.  This family is characterized by a long amino-
terminus that is 500-600 residues in length (Gether, 2000).
Structure and function of Class A receptors
GPCRs are all comprised of a single polypeptide chain and have seven stretches
of mostly hydrophobic residues of 20-30 amino acids, connected by alternating
cytoplasmic and extracellular hydrophilic loops of varying length.  The hydrophobic
stretches are expected to form transmembrane domains which occur as α-helical
“cylinders” traversing the membrane and are arranged such that a central pore is formed
on the extracellular surface (Iismaa et al., 1995).
This structural model for GPCRs is based on high and low resolution of crystal
structures of rhodopsin (Schertler et al., 1993), (Unger & Schertler, 1995), (Schertler &
Hargrave, 1995), (Palczewski et al., 2000) as well as models based on hydropathy
analysis of the primary sequences of GPCRs (Strader et al., 1989). Rhodopsin’s N-
terminus and the three loops between TM II-III, IV-V, and VI-VII are known to be on
the outside surface of the plasma membrane as demonstrated by antibody labeling.  The
expected cytoplasmic location of the other loops has been demonstrated by their
susceptibility to protease digestion and transglutaminase labeling (Hargrave &
McDowell, 1992).
9Most of the receptors known in this family have 1-9 consensus sites for Asn-
linked glycosylation (Asn-X-Ser/Thr, X is any amino acid except Pro or Asp) in the N-
terminus, with only a few exceptions.  A number of receptors also have glycosylation
sites in the first and/or second extracellular loops (Iismaa et al., 1995).  The rhodopsin
and β-adrenergic receptors (βAR) (Hargrave & McDowell, 1992), (Strader et al., 1989)
as well as several others are known to be glycosylated (Iismaa et al., 1995).  The
glycosylation does not appear to have a function in ligand binding or receptor activation,
at least in the β2-adrenergic and m2 muscarinic acetylcholine receptors (Iismaa et al.,
1995).  Glycosylation is important for trafficking and expressing the receptor at the cell
surface, and may be necessary for proper protein folding and function in some cases.
Insertion of the βAR in the membrane is dependent on glycosylation (Strader et al.,
1989).  Removal of one of the N-terminus glycosylation sites in rhodopsin by point
mutation (Thr17→Met) is the cause of a degenerative disease in the human retina
(Hargrave & McDowell, 1992).
Almost all GPCRs have a disulfide bond between two Cys residues on the first
and second extracellular loops, respectively (Iismaa et al., 1995).  The presence of these
two cysteine residues is invariant in all rhodopsins, and is necessary for the proper
folding, glycosylation, and function of rhodopsin (Hargrave & McDowell, 1992).
Replacement of either of these residues in the βAR or the muscarinic acetylcholine
receptor results in altered function and binding characteristics (Strader et al., 1989),
(Iismaa et al., 1995).
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Palmitoylation of the C-terminus appears to be a common structural feature of
Class A GPCRs, including rhodopsin and the adrenergic receptors.  This is expected to
occur at Cys residues in the C-terminus.  Rhodopsin has two adjacent Cys residues that
bear palmitate in a thioester linkage.  The palmitates are expected to intercalate into the
lipid bilayer, creating an additional loop in the C-terminus (Hargrave & McDowell,
1992).  The mutation of the palmitoylation site in the βAR results in a dramatic
reduction in G protein coupling (Iismaa et al., 1995).  Palmitoylation also appears to be
important in the trafficking of GPCRs to the cell surface.  Mutation of palmitoylation
sites leads to the intracellular retention of several receptor types (Qanbar & Bouvier,
2003).  For a complete review of palmitoylation in GPCRs, see Qanbar and Bouvier
(2003).
Extended ternary complex model of receptor activation
The most widely accepted model of GPCR activation has been the ternary
complex model, which was first proposed by De Lean et al. (1980).  This model explains
the cooperative interactions between agonists, receptors, and G proteins.  The model was
extended to include agonist-independent activation of G proteins by GPCRs (Samama et
al., 1993) and the effects of different classes of agonists (full, partial, neutral, inverse)
(Gether & Kobilka, 1998).  The model states that the receptor exists in an equilibrium
between two states, the inactive (R) and the active (R*) states.  The potency of a ligand
is defined by its ability to move the receptor towards the active state, while receptor
activity in the absence of ligands is defined as its equilibrium point between the states.
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Inverse agonists move the receptor equilibrium towards the inactive state (Wess, 1997)
(Gether & Kobilka, 1998).  In the case of rhodopsin, the receptor is covalently bound to
its ligand (retinal), which acts as an inverse agonist until light absorption changes its
conformation and it becomes an agonist (Gether & Kobilka, 1998).
Despite the usefulness of this model, recent evidence suggests that it is not an
accurate model of actual GPCR action.   Gether and Kobilka (1998) have proposed a
model that uses three receptor states to track receptor activation.  In this model, the
unliganded receptor exists in a unique state R that can transition to R0 and R*.  R0 is
stabilized by inverse agonists and R* is stabilized by agonists.  This model allows for
the observation that both regular and inverse agonists can protect receptors from
denaturation and proteolysis, while the R state is unprotected (Gether & Kobilka, 1998).
Ligand-binding by GPCRs
GPCRs do not have a single conserved ligand-binding domain; domains involved
in ligand binding are quite diverse and vary among receptors (Gether & Kobilka, 1998).
Binding of ligands typically involves interactions with specific amino acids in the
extracellular domains and/or the hydrophobic transmembrane core.  In receptors for
smaller ligands, such as the biogenic amines, the ligand binding domain appears to lie
within the hydrophobic core of the protein, while binding sites for larger ligands such as
peptides and proteins, include the N-terminus and extracellular loops (Gether & Kobilka,
1998).
12
In the βAR, ligand binding occurs in the hydrophobic core with contributions
from the side chains of residues from several TM domains.  Deletion of most of the
predicted extracellular and intracellular regions of the βAR by oligonucleotide-directed
mutagenesis does not affect its binding characteristics (Strader et al., 1989).  Single
amino acid substitutions of Asp79 in TM II and Asp113 in TM IIII of βAR resulted in a
decrease of agonist binding.  Ser residues in TM V and VII, two Phe residues in TM VI,
and a Tyr in TM VII also appear to be critical for agonist binding (Strader et al., 1989).
As far as we know, no studies of ligand binding sites have been done for
arthropod neuropeptide receptors.  Among mammalian neuropeptide receptors, the
closest known analog to the insect kinin receptors are the neurokinin receptors.  Site-
directed mutagenesis of the neurokinin 2 (NK2) receptor revealed four residues in
transmembrane domains that are critical for ligand binding.  All of these residues are
near the extracellular side of their respective transmembrane domains.  Mutations of
Gln109 (TM III), Ile202 (TM V), and Gly273 (TM VI) abolished the ability of NK2
receptor to bind neurokinin A, however the mutant receptors were still able to bind the
antagonist SR48968.  Mutation of His198 (TM V) abolished both neurokinin A and
antagonist binding (Bhogal et al., 1994).
The second extracellular loop appears to confer ligand selectivity in some Class
A GPCRs.  In mammalian systems, two receptors mediate the actions of cholecystokinin
and gastrin.  The cholecystokinin B receptor binds both gastrin and sulfated
cholecystokinin peptides with high affinity, while the cholecystokinin A receptor
(CCKAR) binds only the cholecystokinin peptides.  Studies with chimeras of these two
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receptors showed that replacement of the second extracellular loop resulted in the
selective loss of gastrin affinity.  Site-directed mutagenesis of this loop in the CCKBR
indicated a sequence of 5 residues confers the majority of the selectivity for gastrin
(Silvente-Poirot & Wank, 1996).
Conformational changes upon receptor activation
It is theorized that upon agonist binding, conformational changes in GPCRs
result in the exposure of residues in the second and third intracellular loop that are
critical for interaction with G proteins.  Very little is known about the mechanisms by
which agonist binding leads to the conformational changes necessary for an activated
receptor (Gether & Kobilka, 1998).  The nature of the activating ligand can affect the G
protein coupling profile, suggesting that the precise structure of the activating receptor
conformation may depend on the molecular properties of the ligand (Wess, 1997).
On the cytoplasmic side of TM III in all class A GPCRs is a highly conserved
DRY motif that is key to the conformational changes involved in receptor activation.  In
some receptors this motif is present as ERY (Gether 2000) or ERH (Larhammar, 1996),
but in every case the arginine is conserved (Iismaa et al., 1995).  It is believed that this
motif is located in a hydrophilic pocket formed by polar residues from TM I, TM II, and
TM VII, and that upon agonist binding protonation of the aspartic acid residue causes the
arginine to shift out of the hydrophilic pocket (Gether & Kobilka, 1998).  This shift is
key to the exposure of residues in the intracellular loops that promote G protein
activation.  This hypothesis of receptor activation is supported by studies showing that
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mutation of the aspartic acid residue to aspartate in the α1B and the β2 adrenergic
receptor, as well mutation of the corresponding glutamic acid residue to glutamine in
rhodopsin causes constitutive receptor activation (Arnis et al. 1994, Gether 2000).
Activation of rhodopsin has been analyzed by several spectroscopy methods,
which have consistently shown conformational changes resulting in the movement of
TM III and TM VI (Gether & Kobilka, 1998).  TM III makes a relatively small
movement, whereas TM VI rotates in a counter-clockwise direction (as viewed from the
extracellular surface) , and the cytoplasmic end moved away from TM3 (Gether &
Kobilka, 1998).  Spectral analysis of mutant β2 adrenergic receptors also indicates that
TM3 and TM6 rotate in a counter-clockwise direction upon agonist binding (Gether &
Kobilka, 1998).
Interactions with G proteins
Interactions between GPCRs and G proteins occur at the cytoplasmic surface of
the receptors.  In general, regions critical for these interactions have been localized to the
second and third intracellular loops and the C-terminus (Beck-Sickinger, 1996) (Gether
& Kobilka, 1998).  In rhodopsin, proteolytic digestion of the third intracellular loop
abolished its ability to activate transducin (Findlay & Pappin 1986), (Strader et al.,
1989).  Deletion mutagenesis has also shown that the C- and N-terminal ends of
intracellular loop 3 of βAR are critical for coupling to Gs and the activation of adenylyl
cyclase, although deletions from the middle of this loop did not affect the ability of the
receptor to stimulate adenylyl cyclase (Strader et al., 1989).  Additionally, single-residue
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substitutions in intracellular loops 1 and 2 have been shown to attenuate adenylyl cyclase
stimulation by βAR (Strader et al., 1989).
The sequence of the intracellular regions of GPCRs that are expected to interact
with G proteins are highly divergent, and no consensus sequence for G protein
recognition has been identified.  It is suspected that it is the secondary structure of the
intracellular regions that is critical for G protein interactions; these domains are expected
to form amphipathic alpha-helices with a conserved secondary structure that form G
protein interaction sites (Albert & Robillard, 1993).
Each member of the Gα family of proteins has a single guanine-nucleotide
binding site and intrinsic GTPase activity (Fields & Casey, 1997).  There are multiple
Gα subunits that can be grouped into 4 major groups, Gαq, Gαs, Gαi, and Gα12/13 (Hamm,
1998), (Fields & Casey, 1997).  Members of the Gαi subfamily generally inhibit
adenylate cyclase, while Gαs stimulates it.  Gαq activates phospholipase C-β, which
converts phosphatidylinositol 4,5-diphosphate (PIP2) into diacylglycerol (DAG) and
inositol 1,4,5-triphosphate (IP3).  IP3 causes the release of intracellular calcium, and
DAG activates protein kinase C (Lewin, 1997).  The functions of Gα12/13 subunits remain
mostly unknown, but they do appear to stimulate cell growth (Fields & Casey, 1997).  In
murine fibroblasts, Gα12 activates the RhoA protein in a signal transduction pathway that
leads to transcriptional activation and cellular transformation (Fromm et al., 1997).
Heterotrimeric G proteins are classified by the α subunit because of the historical
view that this is the functional component, although it is now clear that the βγ
heterodimer subunit also interacts with receptors and effectors (Fields & Casey, 1997).
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Analysis of the human genome shows there are 27 α, 5 β, and 14 γ G protein subunits.
Based on these numbers, 1890 possible combinations of heterotrimers are possible,
although some combinations do not form in vitro (Albert & Robillard, 1993).  However,
the huge variety of G protein combinations available and receptor selectivity for them
contributes to the complexity of signal transduction by GPCRs.
The first level of selectivity of GPCRs for G proteins is determined by the Gα
subunit.  Generally, each family of receptors will interact with only one Gα group,
although there are some receptors that activate more than one (Albert & Robillard,
1993).  In most cases, activated GPCRs interact with only a limited set of G proteins, as
defined by the Gα subunit.  The selectivity of receptors for G proteins seems to be the
result of many factors, including receptor and G protein sequence, structure, density,
localization of specific heterotrimers (Wess, 1997), and crosstalk from other receptors
(Quitterer & Lohse, 1999) and the composition of the Gβγ subunit (Albert & Robillard,
1993).  Studies of the Gαi/0 family suggest that the ability of receptors to discriminate
between the highly related members of this family is not due to the α subunit alone; the
β and γ are much more divergent, indicating that it is the heterotrimer as a whole that
confers specificity (Albert & Robillard, 1993).
Studies with hybrid GPCRs have indicated that G protein selectivity is primarily
determined by residues in the 2nd intracellular loop and in the C- and N-terminal portions
of intracellular loop 3, with contributions in some cases by the C-terminal tail (Wess,
1997).  Biochemical studies using synthetic peptides corresponding to receptor segments
generally agree well with the chimeric studies, and have shown that peptides
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corresponding to intracellular loop 2 and the C/N terminal regions of intracellular loop 3
can mimic or inhibit receptor interactions with G proteins (Wess, 1997).  In members of
the muscarinic acetylcholine receptor family, a few hydrophobic residues at the N-
terminus of intracellular loop 3 seem to play a key role in G protein selectivity.  These
residues are predicted to form part of the hydrophobic side of an amphiphilic α-helix
along with an aromatic residue that is critical for selectivity of Gq/11 proteins (Wess,
1997).
Receptor conformation also seems, not surprisingly, to be important for G protein
recognition.  In receptors that couple more than one class of G protein, such as the α2A-
adrenergic and luteinizing hormone (LH) receptors, point mutations in regions other than
the receptor/G protein interface have been shown to abolish coupling to one class of G
protein (Wess, 1997).
The receptor-G protein interaction is not a simple case of the receptor affecting
the G protein, as binding of the G protein also affects the receptor.  Generally,
dissociation of the G protein from the receptor decreases its affinity for the agonist
(Fields & Casey, 1997).  Wild-type βAR has a higher affinity for its agonist when Gs is
bound than under conditions that disrupt G protein coupling (Strader et al., 1989).
After a GPCRs activates a G proteins, the activity of the G protein may be
modulated by a Regulator of G protein Signaling protein (RGS).  These proteins bind
directly to activated Gα subunits and stimulate their GTPase activity, leading to a rapid
deactivation of their signal (Hollinger & Hepler, 2002).
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Regulation/Desensitization of GPCRs
Regulation of GPCRs can occur at the transcriptional, translational, and receptor
protein levels, with the latter being best understood.  Upon prolonged exposure to
agonists, GPCRs often show a diminishment of response, often known as desensitization
or adaptation. This down-regulation can be the result of multiple independent processes
such as desensitization, sequestration, and degradation.  Desensitization and
sequestration can occur in a matter of milliseconds to minutes, while down-regulation by
degradation usually requires hours and results in the loss of receptors from cells.
Desensitization can be due to regulation at the level of the receptor, G protein, and
downstream effectors.  However, most desensitization seems to result from the
regulation of the receptor so as to impair its ability to activate G proteins (Pitcher et al.,
1998).
Desensitization is evident in diverse biological processes involving GPCRs
including bacterial chemotaxis, mating responses in yeast, light perception in
Drosophila, and neurotransmission (Pitcher et al., 1998).  Three families of proteins
have been found that participate in receptor desensitization: G protein-coupled receptor
kinases (GRKs), arrestins, and second messenger-regulated kinases such as PKA and
PKC (Lefkowitz, 1998).
The major mechanism of rapid desensitization is receptor phoshorylation by a
GRK followed by the binding of an arrestin (Lefkowitz, 1998).  In mammals, seven
specific GRKs have been found that primarily phosphorylate GPCRs, resulting in a
profound impairment of receptor function (Pitcher et al., 1998; Claing et al., 2002).  In
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rhodopsin, Ser residues are phosphorylated by rhodopsin kinase in a light-dependent
manner.  Phosphorylation allows the receptor to bind arrestin, which prevents interaction
with transducin (Strader et al., 1989).  Several receptor kinases that are theorized to be
involved in desensitization have been found, and most class A receptors have multiple
Ser and Thr residues in the C-terminal tail that may serve as phosphorylation sites.
However, phosphorylation is not always required for receptor desensitization by GRKs.
In some cases, GRK binding alone is enough to inhibit receptor activity in a
phosphorylation-independent mechanism (Dicker et al., 1999).
The study of constitutively active mutant GPCRs has also contributed to our
understanding of receptor regulation.  Several discrete mutations have been found in the
C-terminus of the third intracellular loop of many receptors that result in constitutive
activation (Wess, 1997; Gether & Kobilka, 1998).  One explanation of this observation
is the possibility that these mutations alter the normal conformation of the receptor in a
way that mimics the opening of the intracellular surface normally associated with
activation (Wess, 1997).  Alternatively, important conformational constraints may
maintain the receptor in an inactive state, and that these constraints are released upon
activation allowing key residues to be exposed to the cytosolic G proteins (Gether &
Kobilka, 1998).
The current model of receptor desensitization is that upon agonist exposure,
GRKs phosphorylate the receptor, which allows it to bind a protein of the β-arrestin
family (or for rhodopsin, arrestin).  Binding of the β-arrestin protein prevents the
receptor from interacting with and activating its corresponding G protein (Pitcher et al.,
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1998).  This method of receptor desensitization can reduce G protein activation by as
much as 70-80% in the rhodopsin and β2-adrenergic receptors.  Additionally, binding of
arrestin to phosphorylated receptors appears to initiate the process of endocytosis and
sequestration into recycling endosomes (Pitcher et al., 1998). There are at least six
members of the arrestin family, some of which are found in many tissues and some only
in the retina.
The binding affinity of the β2-adrenergic receptor for β-arrestin is increased 10-
30 times following phosphorylation by GRKs, whereas agonist binding alone has much
less of an effect (Lefkowitz, 1998).  GRK activity appears to be regulated by several
processes, including binding by activated receptors and feedback from the βγ subunit of
activated G proteins.  Other factors that regulate activity include PKC, lipids, and the
calcium–binding proteins recoverin and calmodulin (Lefkowitz, 1998).  It appears that
the free βγ subunit and phosphatidylinositol bisphosphate may interact with a pleckstrin
homology domain in the C-terminus of GRK2 or GRK3, and translocate the GRK to the
activated receptor.  Different βγ isoforms have a preferential affinity for either of the
GRKs, which may lend specificity to the receptor interaction (Lefkowitz, 1998).
Desensitization of GPCRs by their second-messenger regulated kinases provides
a feedback mechanism to regulate receptor activity.  Both PKA and PKC, activated by
Gαs and Gαq respectively, can directly phosphorylate GPCRs.  This phosphorylation
interferes with G protein interactions by modifying the conformation of the receptor
(Lefkowitz, 1998).  This phosphorylation occurs at serine residues in the third
intracellular loop and C-terminus of the β2-adrenergic receptor (Lefkowitz, 1998), and
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many receptors have multiple serines or threonines in these regions, as well as consensus
sites for phosphorylation by PKA or PKC (Iismaa et al., 1995).  However,
desensitization by second-messenger related kinases is not considered agonist specific,
because other pathways may activate these proteins resulting in heterologous
desensitization.
Sequestration of GPCRs by endocytosis may occur by the clathrin-coated vesicle
pathway, or non-clathrin pathways (Lefkowitz, 1998).  For at least some GPCRs,
phosphorylation by a GRK and binding of arrestin are crucial to receptor sequestration.
It has been demonstrated that β-arrestins 1 and 2 directly bind clathrin with high affinity,
and most likely act as an adaptor in the clathrin-coated vesicle mediated endocytosis of
GPCRs (Lefkowitz, 1998; Claing et al., 2002).
Oligomerization of GPCRs and Receptor Activity Modifying Proteins (RAMPS)
The classical view of GPCR function is that only receptor monomers are
responsible for interacting with ligands and effecting receptor functions.  However,
recent evidence that GPCRs form dimers (the simplest form of oligomer), and that these
dimers may serve important functions is challenging this view.  Some of the strongest
evidence for GPCR function as oligomers has come from trans-complementation studies,
where a restoration of function is shown when two mutant or chimeric receptors are
expressed together that have no function by themselves.  For example, chimeric α2-
adrenergic/M3 muscarinic receptors composed of the first five transmembrane domains
of one receptor and the last two of the other showed no binding or function when
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expressed alone.  However, coexpression of the two chimeras restored binding and
signalling in response to both adrenergic and muscarinic agonists (Bouvier, 2001).  A
similar restoration of function results from the co-expression of two binding defective
angiotensin II receptor mutants (Bouvier, 2001).
Dimerization of receptors may explain the complex pharmacological profiles
seen in some receptors that cannot be explained by the ternary complex model.  For
example, among opioid receptors there are many subtypes which  have been identified
pharmacologically, but for which no gene or cDNA has been found.  These receptor
subtypes may in fact be heterodimers of known opioid receptors for endogenous opioid
peptides that have not yet been discovered (Bouvier, 2001).
In addition to the functional evidence of dimerization in mutant receptors, there
is also biochemical evidence for oligomerization of wild-type receptors both in vitro and
in vivo in intact cells.  Solubilized β2-adrenergic receptors differentially expressing Myc-
or HA-tags may be co-immunoprecipated with either anti-HA or Myc antibodies,
indicating intermolecular interaction between the receptors (Bouvier, 2001).  This
approach has also been used to demonstrate dimerization in GABAB, mGluR5, δ-opoid,
calcium, and M3 muscarinic receptors (Bouvier, 2001).  Additionally, the β2-adrenergic,
δ-opoid, mGluR5, and calcium receptor all migrate as molecular species of twice the
expected molecular mass during SDS-PAGE (Bouvier, 2001).
In living cells, fusion constructs between receptors and bioluminescent or
fluorescent proteins have been used to show receptor homodimerization through
fluorescent or bioluminescent resonance energy transfer (FRET or BRET, respectively).
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Homodimers have been detected by BRET or FRET in the absence of agonist, indicating
that some GPCRs can form constitutive dimers in vivo (Bouvier, 2001).  These studies
indicate that homodimers of GPCRs occur naturally in cells, however, there are
conflicting results concerning heterodimers between different receptor types.  Some
research indicates that they are biochemical artifacts resulting from the handling of the
cells, while other research has found evidence for functional heterodimers (Bouvier,
2001).
Studies on the regulation of receptor dimerization have highly variable results
depending on the receptor type.  Exposure to agonists has been shown to increase,
decrease, or have no effect on dimerization in various GPCRs (Bouvier, 2001).
There is clear evidence that dimerization is critical for the proper folding and
cellular transport of the GABAB receptor.  The expression of two isoforms of this
receptor, GABABR1 and GABABR2, is absolutely required for receptor function.  When
both are present, the proteins express at the cell surface and allow a functional response
to GABA.  When expressed alone, GABABR1 is retained intracellularly as an immature
glycoprotein whereas GABABR2 reaches the cell surface but cannot bind GABA or
effect signal transduction (Bouvier, 2001).
The issue of how receptor dimerization may effect signal transduction remains
highly debated.  The requirement of GABABR1 presence before GABABR2 can bind
agonist strongly suggests the formation of a dimmer, although it may just be that
GABABR1 is necessary for the proper folding of this receptor.  A peptide derived from
the proposed dimerization interface of the β2-adrenergic receptor has been shown to
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inhibit dimerization and the stimulation of adenylyl cyclase by this receptor.
Additionally, FRET studies of the LH receptor have shown FRET between wild-type
receptors but not between mutants that are capable of binding agonist but are unable to
induce signal transduction.  This may indicate that the mutants are unable to form
dimmers, and thus are unable to transmit the signal.
Although current knowledge is too limited to propose a molecular model for the
formation of receptor dimers, they clearly exist and may add a level of complexity to
GPCR function that is currently beyond our understanding.  What is clear is that as we
gain more information, GPCR function appears to be more complex than previously
imagined.  Novel protein-protein interactions between GPCRs and receptor activity
modifying proteins (RAMPS) have been shown to be involved in trafficking of the
calcitonin receptor to the cell surface and its phenotypic expression.  RAMPS can
modify receptor phenotype by causing changes in receptor glycosylation and by
interacting directly with the receptor to define the ligand-binding pocket (Sexton et al.,
2001).  The recent identification of the RAMP family of proteins may cause speculation
on the existence of other receptor modulating proteins.
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CHAPTER II
CLONING AND TRANSCRIPTIONAL EXPRESSION OF THE FIRST
ARACHNID NEUROPEPTIDE RECEPTOR FROM THE SOUTHERN
CATTLE TICK, Boophilus microplus (ACARI: IXODIDAE)*
Introduction
The southern cattle tick or cattle fever tick, Boophilus microplus, is the most
important tick-pest of cattle in tropical and sub-tropical regions of the world because of
its ability to transmit Babesia spp., the hemoparasites that cause cattle fever (Nunez et
al., 1985).  Ticks cause greater economic losses in livestock production worldwide than
any other group of external parasites (Bowman et al., 1996).  The compounded
economic impact of cattle fever and tick parasitism prior to their eradication from the
southern U. S. A. in 1960 was estimated at over one billion dollars annually (Graham &
Hourrigan 1977).  However, the ongoing detection of sporadic outbreaks of this tick in
southern Texas is evidence that reintroduction of this pest to the U.S. presents a serious
threat (Anonymous, 2000).  Control of B. microplus has become increasingly difficult
worldwide because it has rapidly developed resistance to pesticides.  In Australia, where
strains of the tick are resistant to all commonly used acaricides (Baxter & Barker, 1999),
the loss to the cattle industry is one hundred million dollars annually (Angus, 1996).  In
                                                
* Text and figures reprinted with permission from “Cloning and transcriptional expression of a leucokinin-
like peptide receptor from the southern cattle tick, Boophilus microplus (Acari: Ixodidae)” by Holmes et
al., 2000. Insect Molecular Biology, 9, 457-465.  Copyright 2000 by Blackwell Science Ltd.
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Mexico, resistance to organophosphates (Rosario-Cruz et al., 1997) and pyrethroids (He
et al., 1999) has been reported.
One effective control strategy for the southern cattle tick may be endocrine
disruption.  Mimetics of ecdysone and juvenile hormone, such as tebufenozide and
methoprene, respectively, are effective insecticides (Wing et al., 1988; Jones, 1995).
However, a third group of currently unexploited hormones, the peptide hormones, may
have a great potential for control because they are master regulators and affect a number
of physiological processes (Keeley & Hayes, 1987).  In order to develop neuropeptide
mimetics useful in pest control, the chemical and conformational requirements of
neuropeptide-receptor interactions must be understood (Nachman et al., 1993).
Although many neuropeptides have been isolated from insects (Nässel, 1996), very few
of their receptors have been identified.
The myokinins or leucokinin-like peptides are a family of neuropeptides that
have been found in several arthropod and invertebrate groups (Nässel, 1996).  They have
myotropic and diuretic activity in insects.  Myokinins stimulate hindgut contractions in
the cockroach, cricket, and locust (Holman et al., 1987; Holman et al., 1990; Schoofs et
al., 1992) and increase the rate of secretion in Malpighian tubules (Pannabecker et al.,
1993; Veenstra et al., 1997; O'Donnell et al., 1998; Cady & Hagedorn, 1999a; Holman
et al., 1999; Terhzaz et al., 1999).  Myokinins may also serve as neuromodulators of the
central nervous system (CNS) (Nässel, 1996; Nässel 2002).  Because of their
multifunctional activities, myokinin receptors may represent an excellent target for the
development of acaricidal and insecticidal mimetics.  The first member of the myokinin
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or leucokinin-like receptor subfamily is the lymnokinin receptor, cloned from a mollusc,
the pond snail Lymnaea stagnalis (Cox et al. 1997).  The first myokinin receptor known
from an arthropod was cloned from the southern cattle tick B. microplus, and is the
subject of this dissertation (Holmes et al., 2000; Holmes et al., 2003).  Analysis of the
Drosophila genome predicted that gene product CG10626 was a myokinin receptor
(Holmes et al., 2000; Hewes & Taghert, 2001).  This prediction was shown to be correct
by the functional expression of the receptor in S2 cells.  Exposure to drosokinin induced
a intracellular calcium response in transfected cells (Radford et al., 2002).  Additionally
there is one report on the biochemical characterization of a 54 kDa leucokinin binding
protein from the mosquito Aedes aegypti (Pietrantonio et al., 2000), and a report on an
achetakinin binding site in the Malpighian tubule of the cricket Acheta domesticus
(Chung et al., 1995).
 Polymerase chain reaction (PCR) and other molecular techniques were used to
obtain a cDNA of a novel myokinin receptor from the southern cattle tick, B. microplus.
Here we report the characterization of this cDNA and show the developmental
expression of this receptor by reverse transcription (RT)-PCR experiments.  This work
constitutes the first evidence of leucokinin-like regulated signal transduction in the
Acari.  The myokinin receptor is the first neuropeptide receptor to be cloned from the
Acari, the second G-protein coupled receptor (GPCR) known from B. microplus, and the
second member of the leucokinin-like receptor subfamily.  In addition, based on the
sequence similarity of the Boophilus receptor to the gene product CG10626 in the
recently published D. melanogaster genome (Adams et al., 2000), we predicted that
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CG10626 may constitute the first identified insect myokinin receptor (Holmes et al.,
2000).
Methods
Ticks
Southern cattle ticks (B. microplus) were from the Gonzalez strain, a pesticide
susceptible strain that is maintained at the Cattle Fever Tick Research Laboratory,
USDA-ARS, Mission, TX.  This strain was originally obtained from an outbreak in
Zapata County, TX, in 1994.  Eggs were collected after engorged females were allowed
to oviposit in a humidified incubator at 24°C.  Unfed larvae were collected after being
raised in the incubator for ten days.  Nymphs were obtained by placing larvae on cattle,
then collecting them ten days after their nymphal molt. Adults were also raised on cattle
and collected 15 days after their final molt. Ticks were frozen and stored at -80°C until
use.
cDNA synthesis and cloning
Double-stranded cDNA was prepared by Dr. Haiqi He (USDA Southern Plains
Agricultural Research Center, College Station, TX) according to the following methods.
Total RNA was purified from tick larvae using TRIzol Reagent (Life Technologies,
Gaithersburg, MD) following the manufacturer’s protocol.  Poly-A+ RNA was purified
from the total RNA using an Oligotex mRNA Kit (Qiagen, Santa Clarita, CA).
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Double-stranded cDNA was synthesized using the Marathon cDNA Amplification Kit
(Clontech, Palo Alto, CA).
PCR reactions were conducted in a PTC-200 Peltier Thermal Cycler or PTC-100
Programmable Thermal Controller (MJ Research Inc., Watertown, MA).
Oligonucleotide primers were synthesized by Genosys Inc. (Houston, TX).  All reactions
were carried out in 50 µl volumes containing Clontech KlenTaq polymerase (1 µl),
Clontech 10x cDNA PCR Reaction Buffer (5 µl), 0.2 mM each of four dNTPs and
primers to final concentrations of 1 µM (degenerate) or 0.2 µM (specific primers) each.
Marathon cDNA was used as the template for PCR with two degenerate
oligonucleotide primers.  Negative control reactions contained only one primer of the
pair.  These primers correspond to DNA sequences within the conserved regions of
transmembrane regions III and VI of many G protein-coupled receptors (Cox et al.
1997): sense 5’-CCG GAT CCG (CT)(GC)A T(CT)(GA) (GC) (GC)I T(GT)G AC(CA)
G(GC)T A-3’ and antisense 5’-ACG AAT TCG G(GC) (CA) ICC A(GA)C AGA
I(GC)(GA) (CT)(GA)A A-3’.  PCR conditions were: initial denaturation at 94°C for 1
min followed by 8 cycles of 94°C for 20 sec, and an annealing/extension step of 72°C
for 1.5 min that was decreased by 0.5°C per cycle, followed by 40 cycles of 94°C for 20
sec (denaturation), 68°C for 1.5 min (annealing/extension) then a final extension of 5
min at 68°C.
RACE PCR
            Four sequence specific primers were designed to amplify the 5’ and 3’ ends of 
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 the cDNA in RACE (rapid amplification of cDNA ends) PCR.  Sense primer sequences
were: 1F, (5’-AGT TCA TCA TCT GCG GTA TCT GGA C-3’); 2F, (5’-GTC TCA
CGC GCT CAA CCT GAC TAA G-3’).  Antisense primers: 3R, (5’-CAG ACA CAC
GAG GAC GTG GTT ATA G-3’); 4R, (5’-GTA CAC GAA ACA GAT GGT GAG
CAG C-3’).  Primers 2F and 3R corresponded to sequence regions interior to those of
primers 1F and 4R, respectively.  During synthesis of Marathon cDNA, adaptors were
ligated to the ends of all cDNAs.  Primers complementary to the adaptor sequence AP1
(external) and AP2 (internal) are supplied with the Marathon kit.  Primers 1F and AP1
were used in the initial 3’ RACE PCR.  Primers 4R and AP1 were used in 5’ RACE.
Initial RACE products were diluted and amplified in a nested 3’ RACE reaction
with 2F and AP2 primers and a nested 5’ RACE reaction with primers 3R and AP2.
Final primer concentrations were 0.2 µM in 50 µl volumes.  Cycling parameters for the
initial RACE were: 94°C for 1 min, 5 cycles of 94°C for 20 sec and 72°C for 1.5 min, 5
cycles of 94°C for 20 sec and 70°C for 1.5 min, 26 cycles of 94°C for 20 sec and 68°C
for 1.5 min, and a final extension step of 68°C for 5 min.  Cycling parameters for the
nested RACE reactions were: 94°C for 1 min, 25 cycles of 94°C for 20 sec and 70°C for
1.5 min, and a final extension step of 68°C for 5 min.  Products were separated on an
agarose gel and bands of the sizes 2.0 kb from the 3’ reaction and 0.8 kb from the 5’
reaction were cut.  The DNA was extracted using the Qiagen Quickgel extraction kit.
PCR products were cloned into pCR 2.1 or pCR-TOPO plasmid vectors (Invitrogen,
Carlsbad, CA) and electroporated into Electrocomp Topo 10F’ cells or heat-shocked
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into Ultracomp Topo 10F’ cells (Invitrogen), respectively.  Positive colonies were
selected with blue-white screening and plasmids were purified using Wizard Plus
Minipreps (Promega Corp., Madison, WI).
Sequencing reactions were performed with AmpliTaq DNA polymerase and
fluorescent dideoxynucleotides according to manufacturer’s protocols (PE Applied
Biosystems 1998), and the reaction products were electrophoresed and analyzed on an
automated DNA sequencer (Applied Biosystems model 373) by the Gene Technologies
Laboratory at Texas A&M University.  Sequences were analyzed using DNASTAR
software (DNASTAR, Inc., Madison, WI).
Semi-quantitative RT-PCR
Methods used for semi-quantitative RT-PCR were similar to those described by
Dozois et al. (1997).  Whole tick samples (50 mg) of each life stage (eggs, larvae,
nymphs, and adults of both sexes) were ground under liquid nitrogen with a mortar and
pestle.  Poly-A+ RNA was purified from the ground samples using a Dynabeads
mRNA Direct kit (Dynal, Oslo, Norway).  First strand cDNA was synthesized from one
tenth of the Poly-A+ RNA at 42°C for 50 min with oligo(dT)12-18 primer using
Superscript II Reverse transcriptase (Superscript Preamplification System, Life
Technologies).  PCR amplification of β-actin cDNA was performed using primers Act-
3F, 5’-TCC TCG TCC CTG GAG AAG TCG TAC-3’, and Act-4R, 5’-CCA CCG ATC
CAG ACC GAG TAC TTC-3' specific to the B. microplus β-actin gene.  The gene
sequence was obtained by PCR using primers that correspond to conserved regions of
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insect actin genes (H. He, unpublished).  Reactions contained one-tenth (2 µl) of the
synthesized cDNA, 200 µM each of four dNTPs, 0.2 µM of each primer, 1 µl Taq
polymerase, and 1X reaction buffer (Boehringer Mannheim) in a final volume of 50 µl.
Taq was added after the reaction was brought to 94°C.  The following cycling
parameters were used: 94°C for 1 min followed by 25 cycles of 94°C for 20 sec, 62°C
for 30 sec, and 72°C for 45 sec. PCR amplification of receptor cDNA was performed
using primers designated SC2-F, 5’-CTC CGG GAA GTT TTC CTA AAG A-3’, and
SC3-R, 5’-TGG TGG TTG GAC TCA AAT TAC AC-3’.  PCR conditions were
identical to the actin PCR amplification except that 35 cycles were used to amplify the
receptor cDNA.  Five microliters of each actin reaction and 20 µl of each receptor
reaction were electrophoresed on 1% TBE agarose gels containing ethidium bromide.
Gels were photographed with Polaroid film and the images were scanned with a Hewlett
Packard ScanJet 3c.  The intensity of the bands was determined using Kodak Digital
Science 1D software (Kodak Scientific Imaging Systems, New Haven, CT).  The relative
level of receptor RNA in each tick stage was indirectly estimated by the ratio of the
intensity of the receptor band to that of the actin band.
Southern blot
To assure that the RT-PCR products corresponded to the cloned receptor, each
was diluted 1:500 and reamplified in a 100 µl reaction using the same reagents and
concentrations as the original RT-PCRs.  The following cycling parameters were used:
94°C for 1 min followed by 40 cycles of 94°C for 20 sec, 60°C for 30 sec, and 72°C for
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30 sec.  Twenty microliters of each reaction was run on a TBE 1% agarose gel that was
photographed. DNA was transferred to S&S Nytran membrane (Schleicher and Schuell,
Keene, NH) using standard upward blotting techniques following alkaline denaturation
(Ausubel et al. 1995).  After transfer, the blot was baked at 80°C for 30 min, then U.V.
crosslinked for 3 min on a transilluminator.
In order to unequivocally confirm that the amplified products were receptor-
specific, a receptor DNA fragment (base pairs 986-1304) (Fig. 2) was cloned and
sequenced to serve as a template for a radiolabeled probe for Southern blots.  For this,
the Ambion DECAprime II Random Priming DNA Labeling kit (Ambion, Austin, TX)
was used with α-32P dCTP (NEN Life Science Products, Boston, MA).  The blot was
allowed to hybridize overnight at 42°C in ULTRAhyb (Ambion), then washed 2x 5
min in 1x SSC, 0.1% SDS at 42°C then 2x 15 min in 0.1x SSC, 0.1% SDS at 50°C.  The
blot was then exposed to Kodak Biomax™ ML film (Eastman Kodak, Rochester, NY).
Results
The PCR with degenerate primers corresponding to transmembrane (TM) regions
III and VI, highly conserved in many GPCRs (Cox et al. 1997), amplified DNA products
of about 450 bp and 600 bp.  Comparisons to the GenBank database showed that the
amplified sequence of 450 bp was most similar to those of the kinin receptor family.
Nested gene-specific primers were then designed on the basis of the nucleotide sequence
of the 450 bp PCR product and used in 5’ and 3’(RACE) to amplify the full length
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receptor cDNA.  The primers were designed to encompass the majority of the 450 bp
product in the 3’ and 5’ RACE reactions, respectively, to unequivocally obtain the
corresponding cDNA ends.  The 3’ RACE product was 2 kb and the 5’ RACE product
was 850 bp.  The sequences of the 3’ and 5’ RACE fragments were identical to each
other in the expected region of overlap.  The full-length cDNA was 2.7 kb, out of which
1541 bp are shown in Fig. 2.  The complete sequence has been deposited in GenBank
(AF228521).
The identified open reading frame (ORF) consists of 1194 bp and encodes a
protein of 397 residues with a predicted molecular mass of 44.9 kDa (Fig. 2).  Two
possible start codons, beginning at positions 95 and 123, were identified within an ORF
that terminates with a stop codon at position 1286.  The first ATG at positions 95-97 was
presumed to be the actual start codon because neighboring bases more closely matched
the optimal sequence for translation initiation, GCC(A/G)CCATGG (Lewin, 1997).
Blast P searches of GenBank showed that this sequence encoded a G protein-
coupled receptor that was similar to the lymnokinin receptor from pond snail (40.3 %
identity) (Cox et al., 1997) and other invertebrate neuropeptide receptors (Fig. 3, Table
1).  The predicted gene product from the D. melanogaster genomic sequence, CG10626,
resulted 46.9 % identical to the B. microplus receptor sequence.  These sequences were
analyzed for similarity with DNASTAR (Table 1, Fig. 3).  Kyte and Doolittle
hydrophilicity plots of the B. microplus receptor, lymnokinin receptor, and CG10626
(Fig. 4) reveal seven putative transmembrane regions.  In the B. microplus receptor, two
cysteine residues, Cys 128 and Cys 210, located in the first and second extracellular
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loops, respectively, are expected to form a disulfide bond.  The location of these residues
is consistent in almost all GPCRs (Watson & Arkinstall, 1994; Schöneberg et al., 1999).
The N-terminal region contains two asparagine residues, Asp 30 and Asp 41, within a
glycosylation consensus sequence N-X-S/T (Lewin, 1997).  There is also a third
glycosylation site, Asp-204, in the predicted second extracellular loop.  Two cysteine
residues in the intracellular C-terminus (Cys 348, Cys 350) represent likely sites for
palmitoylation (Iismaa et al., 1995).
The receptor sequence used for semi-quantitative RT-PCR experiments and
synthesis of the probe for the Southern blot corresponds to the C-terminus, the region
known to be the least similar among GPCRs from the same subfamilies and thus often
used to identify specific receptors.  In order to ensure specificity, the antisense primer
was designed within the 3’ untranslated region and the sense primer in a region of low
similarity corresponding to the third extracellular loop (Figs. 2 and 5).  Receptor
messenger RNA (mRNA) was present in all life stages of the southern cattle tick as
determined by semi-quantitative RT-PCR (Fig. 5A).  These results suggested that
receptor expression was highest in larvae and adult females.  In these experiments the
amount of amplified receptor cDNA produced by RT-PCR (318 bp, Fig. 5A) had been
normalized by comparison with the amplification of tick β-actin (330 bp, Fig. 5A).  A
pixel-density analysis indicated that the maximal amplification of receptor PCR product
was in females, followed by larvae, eggs, nymphs and males (Fig. 5A).  The amplified
products were confirmed to be identical to the cloned receptor by Southern blot (Fig.5B).
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CGCTAAGCGCGGTCGGCA 18
GCATTCGCGCGCCGCTCGGCAATCCGCGCGCACCACGAACGGCCGTTCCGCTATGGTGCCACA 81
ATG ACC TCG CTG CCC GGC ATG ACC CTC GAC CCG TCG GCT CCG CCA CCC 129
M T S L P G M T L D P S A P P P 16
CTG CTG CTG GAC AGC TCG TAC GTG TCA CCG GAC TAC GGG AAC CTG TCG 177
L L L D S S Y V S P D Y G N L S 32
♦
CTG CTG TCA TCG TTG CCG GCA GCA AAC ATC AGT TCC AAC AAG TTG TAC 225
L L S S L P A A N I S S N K L Y 48
♦
CAG GTT CCC GTC GGC TTC ATC GTG CTC CTC TCC ATA TTC TAC GGC ATC 273
Q V P V G F I V L L S I F Y G I 64
ATA TCA CTG GTG GCC GTC GCC GGC AAC TTC ATG GTC ATG TGG ATC GTG 321
I S L V A V A G N F M V M W I V 80
GCC ACG TCA CGG CGC ATG CAG ACA GTC ACC AAC TTC TTC ATC GCC AAT 369
A T S R R M Q T V T N F F I A N 96
CTG GCC GTA GCC GAC ATC ATC ATC GGA CTG TTC TCC ATC CCG TTC CAG 417
L A V A D I I I G L F S I P F Q 112
TTC CAG GCA GCT CTG CTG CAG CGC TGG GTG CTG CCC GAG TTC ATG TGC 465
F Q A A L L Q R W V L P E F M C 128
GCC TTC TGC CCC TTC GTA CAG GTG CTC TCG GTC AAC GTG TCC ATA TTC 513
A F C P F V Q V L S V N V S I F 144
ACG CTG ACC GCC ATC GCA CTG GAC CGC TAC CGC GCC GTC ATG TCG CCC 561
T L T A I A L D R Y R A V M S P 160
CTT AAG GCT CGC ACC ACC AAG CTG CGC GCA AAG TTC ATC ATC TGC GGT 609
L K A R T T K L R A K F I I C G 176
ATC TGG ACG CTC GCG GTT GCG GCC GCT CTG CCG TGC GCA CTC GCT CTG 657
I W T L A V A A A L P C A L A L 192
CGT GTC GAG ACG CAG GTC GAG TCT CAC GCG CTC AAC CTG ACT AAG CCG 705
R V E T Q V E S H A L N L T K P 208
♦
TTC TGC CAC GAG GTT GGC ATT TCG CGC AAG GCC TGG CGC ATC TAT AAC 753
F C H E V G I S R K A W R I Y N 224
CAC GTC CTC GTG TGT CTG CAG TAC TTT TTC CCG CTG CTC ACC ATC TGT 801
H V L V C L Q Y F F P L L T I C 240
Figure 2.  Nucleotide and deduced amino acid sequence of the myokinin receptor cDNA from the
southern cattle tick, B. microplus (GenBank/EMBL accession number AF228521).  Amino acids
corresponding to predicted transmembrane regions have been underlined.  Possible glycosylation
sites are marked with a diamond.
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TTC GTG TAC GCG CGC ATG GGC CTC AAG CTC AAG GAG AGC AAG TCT CCC 849
F V Y A R M G L K L K E S K S P 256
GGC AAT GCC CAG GGT GCG CGC GAC GCC GGC ATC CTC AAG AAC AAA AAG 897
G N A Q G A R D A G I L K N K K 272
AAG GTG ATC AAG ATG CTG TTT GTC ATC GTG GCA CTG TTC GCC TTT TGC 945
K V I K M L F V I V A L F A F C 288
TGG CTC CCT TAT CAG TTA TAC AAC ATT CTC CGG GAA GTT TTC CCA AAG 993
W L P Y Q L Y N I L R E V F P K 304
ATT GAC AAG TAC AAG TAC ATA AAC ATA ATC TGG TTC TGT ACA CAC TGG 1041
I D K Y K Y I N I I W F C T H W 320
CTG GCC ATG AGT AAC TCC TGC TAC AAT CCT TTC ATT TAT GCC ATC TAC 1089
L A M S N S C Y N P F I Y A I Y 336
AAC GAG CGC TTC AAG CGC GAG TTC GCC ACT CGC TGT ACT TGC GGC GGT 1137
N E R F K R E F A T R C T C G G 352
CAT CGC TAC AAG TCC CCC AAG AGC CGC TTC GCC TCG TAC GAG CAG GAA 1185
H R Y K S P K S R F A S Y E Q E 368
GAC AAC TCG ACC ATC ATT GTG TCT ATG CGG CAC TCA TTC CGG CTG AGC 1233
D N S T I I V S M R H S F R L S 384
♦
TTC AAG AAT TCC GCG CCG CTC AAA GCG AGC ACG CAG GTG TAA 1275
F K N S A P L K A S T Q V 397
TTAGAGTCAACCACCAGTGAAATCCTATCAGTGCACGTGCATCGGGAAGAAGAAACAGGAGAC 1338
TGAGCGGSGCCCCCTAYTTCCTTCGTGGCGCTTTCTYCGCGACGATGGTGATATCTGTGCATG 1401
TTGAACCCGATCTGCGCAGCACCCATTTGCAAATGCGCCAGCCCGGAAGGCGACCACCCGCCA 1464
TGGCTCAAATGGCCGTGCCCCACCGACCTGCTTCAACACGGAACTTGAGCCCTGAACTTGACC 1527
ACCGGGCGCAATTATGTCCAAGCGAGGGAAGTGCACGTGTGTATGYGCGTGTATGCGTGCCTG 1590
TGTGTTGTTTGACTTGTGTCTYTTATTCCGATCTATTCGGTGGTAAAGAGACGCTGCGAGGAA 1653
TGTCGGGCTCTACCGACTTCGAGGCTTGCTGCGTGAAAACGATATTTTGTGCGAGTCAGAGCA 1716
TGTATTGGCGTTTTCGCAGCGCCGAGTTTGACGTCCGGCATCCGTGTGTGTATATACCATTGT 1779
ATAAGGATAGCCTCGAGCTCCCCAGACATCGACAGATACTAAGAGTGTACGTGCAGGGACTGT 1842
TGTCTTTCATGAGTGTTTTTTTCGACCTGCTTTCTTGCTTGCAGCTGTCTCCACGCTGTGTTA 1905
TCCGGGTAATAAAATGAAAAGACCGCGCGCTCGTCTGYCTGTCGCCTCACGTGCGAGATTACT 1968
GGGCACGATCATYATCACAGTCATGCTCGTTCGAAAAGCCTATAATACGTGCGCTTAAGGTGC 2031
TTTGTCACGGTACGTCCTCGTAATGTACATGAAATTTGTCCTCAACCTACCATGGATATGAAA 2094
GTAGCAGTTGAATTGTTATGACCTGTTACATTTTTGTTTACTCTGACTCATCTAAGAAAACAT 2157
AGAGGAATGCAACTCTGGGAGGGATTCAAAAGTGTCATCGTGCGACAATCTTGAAGCCAAGTC 2220
ATAAAAAATGAAGGAGCAAACAGGCCCTAGTTACGTGTTAGGCAAGTGCTATATTTGTCGRCT 2283
CGCTTTGGTTGCGTCTGCTGCGGGRGCTTCGGTGGTCTCATCCTACCTAGAAGGCACCGCGCG 2346
CTAGTCCAAAGGGGCAGCGTCCCAGGAAGTTCACTAATTGTCAAAAGCTAGCGGTTTTAGGTG 2409
ACACTCCCTCCCAGTTCCTTYCTTCCYYCATGTCTACAAGAAGGGTGAGTGTACAATAATGGG 2472
GTGAACCCGAACATATAGTTAGTGCGTTTCCGTTCAGTTTATTATTTTTTAGTCAGTGCTTAA 2535
ATCTGGGTGTTGTACTTATTTAAAAATAGAATTACGAAAAAAAAAAAAAAAAAAAAAAAAA 2596
Figure 2.  Continued.
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Figure 3.  Amino acid alignment of the B. microplus myokinin receptor (Bm myo), with candidate
invertebrate myokinin receptors.  Identical residues are noted as white text on a black background.
Aligned sequences are the cg10626 gene product (D. melanogaster drosokinin receptor) and the L.
stagnalis lymnokinin receptor (LSR) (U84499).
 M T S L P G M T L D P S A P P P L L L D S S Y V S P D - - - 28Bm myo 
M D - - - - - - - - - - - - - - - L I E Q E - - - - - - - - 8cg10626 
M S Q I E S M S - - - E Q A A V I F I E Q A N Q D L D N V S 27LSR 
- - - - - - - - Y G N L S L L S S L P A A N I S S N K L Y Q 49Bm myo 
- - - - - - - - - S R L E F L P G - A E E E A E F E R L Y A 27cg10626 
G N D V S S F F Y N E T T T L - - F P G S N E S F V M P Y D 55LSR 
V P V G F I V L L S I F Y G I I S L V A V A G N F M V M W I 79Bm myo 
A P A E I V A L L S I F Y G G I S I V A V I G N T L V I W V 57cg10626 
V P T G L I C L L A F L Y G S I S L L A V I G N G L V I L V 85LSR 
V A T S R R M Q T V T N F F I A N L A V A D I I I G L F S I 109Bm myo 
V A T T R Q M R T V T N M Y I A N L A F A D V I I G L F C I 87cg10626 
I V K N R R M H T V T N I F I P N L A V S D V I I G L F S I 115LSR 
P F Q F Q A A L L Q R W V L P E F M C A F C P F V Q V L S V 139Bm myo 
P F Q F Q A A L L Q S W N L P W F M C S F C P F V Q A L S V 117cg10626 
P F Q F Q A A L L Q R W V L A N F M S S L P P F V Q V V T V 145LSR 
N V S I F T L T A I A L D R Y R A V M S P L K A R T T K L R 169Bm myo 
N V S V F T L T A I A I D R H R A I I N P L R A R P T K F V 147cg10626 
N L T I F T L R V I A V D R Y I A V I H P F K A G C S K K R 175LSR 
A K F I I C G I W T L A V A A A L P C A L A L R V E T Q V E 199Bm myo 
S K F I I G G I W M L A L L F A V P F A I A F R V E E L T E 177cg10626 
A A I I I S I I W A V G I G A A L P V P L F Y W V E D L T E 205LSR 
- - - - - S H A L N L T K P F C H - E V G I S R K A W R I Y 223Bm myo 
R F R E N N E T Y N V T R P F C M - N K N L S D D Q L Q S F 206cg10626 
N - - - - - - - - N I V I P R C D W H A P D N W L D F H L Y 227LSR 
N H V L - V C L Q Y F F P L L T I C F V Y A R M G L K L K E 252Bm myo 
R Y T L - V F V Q Y L V P F C V I S F V Y I Q M A V R L W G 235cg10626 
Y N T L L V C F Q Y L L P L V I I T Y C Y C R I A W H I W G 257LSR 
S K S P G N A Q G A R D A G I L K N K K K V I K M L F V I V 282Bm myo 
T R A P G N A Q D S R D I T L L K N K K K V I K M L I I V V 265cg10626 
S R R P G - A H V T T E D V R G R N K R K V V K M M I I V V 286LSR 
A L F A F C W L P Y Q L Y N I L R E V F P K I D K Y K Y I N 312Bm myo 
I I F G L C W L P L Q L Y N I L Y V T I P E I N D Y H F I S 295cg10626 
C L F V L C W L P L Q M Y N L L H N I N P L I N H Y H Y I N 316LSR 
I I W F C T H W L A M S N S C Y N P F I Y A I Y N E R F K R 342Bm myo 
I V W F C C D W L A M S N S C Y N P F I Y G I Y N E K F K R 325cg10626 
I I W F S S N W L A M S N S C Y N P F I Y G L L N E K F K R 346LSR 
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E F A T R - - - C T C - - - - - - G G H - - - - - - - - R Y 355Bm myo
E F N K R F A A C F C K F K T S M D A H E R T F S M H T R A 355cg10626
E F H Q L F V M C P C - W K A R V D Y Y T E Y F S - - - - - 371LSR
K S P K S R F A S - - - - - - - - - - - - - - - - - - - - - 365Bm myo
S S I R S T Y A N S S M R I R S N L F G P A R G G V N N G K 385cg10626
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 371LSR
- - - - - - - - - - - - - - - - - Y - - - - - - - - - - - - 366Bm myo
P G L H M P R V H G S G A N S G I Y N G S S G Q N N N V N G 415cg10626
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 371LSR
E Q E D N S T I I - - - - - - - - - - - - - - V S M - - - - 378Bm myo
Q H H Q H Q S V V T F A A T P G V S A P G V G V A M P P W R 445cg10626
- - - E D A N I C R R A N T N G - - - - - - - - - - - - - - 384LSR
R H S F R - - - - - - - - - - - - - - - L S F K N S A P - - 391Bm myo
R N N F K P L H P N V I E C E D D V A L M E L P S T T P P S 475cg10626
- - - - - - - - - - - - H C - - - - - - - - - P A N R H G A 392LSR
- - L K A S T Q V 397Bm myo
E E L A S G A G V Q L A L L S R E S S S C I C E Q E F G S Q 505cg10626
V G T T S T E T T R K S M L S R - - - - - - - - - - - - - - 409LSR
397Bm myo
T E C D G T C I L S E V S R V H L P G S Q A K D K D A G K S 535cg10626
S R C K G T - - - - - - - R R R R Q T Y D E R R E T S S 429LSR
397Bm myo
L W Q P L 540cg10626
429LSR
Figure 3.  Continued.
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Table 1.  Amino acid identity of the B. microplus receptor to other invertebrate myokinin or related
neuropeptide receptors and probability values from Blast searches.
Receptor Identity Blast P Probability
Drosokinin
Drosophila melanogaster (fruit fly)
46.9 % 1e-100
Lymnokinin
Lymnaea stagnalis (pond snail)
40.3 % 2e-79
Tachykinin-like
Stomoxys calcitrans (stable fly)
29.0 % 1e-50
Neuropeptide y
Drosophila melanogaster
28.0 % 2e-49
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Figure 4.  Kyte and Doolittle hydrophilicity plots of (A) the B. microplus myokinin receptor, (B)
the L. stagnalis lymnokinin receptor, and (C) the Drosophila drosokinin receptor.   Negative
values indicate hydrophobic regions of the proteins.  All receptors show a similar structure of
seven putative transmembrane regions, characteristic of GPCRs. The figure was created with
DNASTAR software.
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Egg   L       N          Adult
                                  ♀        ♂
β-actin
Receptor1
2
A
% Female
Expression              84        93       79     100    76
Ratio: receptor     0.359       0.399    0.339    0.428  0.324
               β-actin
                                         Adult
( - )    Egg    L     N     ♀    ♂B
1
2
Figure 5.  (A) Semi-quantitative RT-PCR of each life stage shows the relative amount of amplified
receptor transcripts (Panel 1) in comparison to amplified tick β-actin transcripts (Panel 2).  PCR
products were obtained using single-stranded cDNA as the template.  Note the higher intensity of
receptor products in larvae and females. (B) Agarose electrophoresis of amplified receptor PCR
products preparatory for Southern blot (Panel 1).  Panel 2: Autoradiograph of the Southern blot of
DNA in panel 1.  Lane 1: negative control reaction (-) containing control cDNA not related to the
receptor (Superscript™ preamplification system, Life Technologies).  Lanes 2-5: PCR products
corresponding to amplified receptor fragments from each life stage. N = nymphs, L = larvae.
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Discussion
The myokinin receptor we have identified from the southern cattle tick B. microplus is
the first neuropeptide receptor cloned from a tick and the second receptor identified in
this species.  Only six other receptors have been cloned from ticks.  Three of these are
GPCRs, an octopamine-like receptor (AJ0107043) (Baxter & Barker 1999) and two
serotonin receptors cloned in our lab (Chen et al., 2003; S. Holmes, unpublished data)
from B. microplus.  There are also three nuclear receptors from Amblyomma
americanum, an ecdysone receptor (AF020189) (Guo et al. 1997) and two retinoic x
receptors (Palmer et al. 1999) (AF035577 and AF035578).
Knowledge of tick endocrinology is limited (Sonenshine, 1991; Lomas, et al.
1997).  However, by analogy with insects, tissues expressing leucokinin receptors in
ticks may be involved in water balance or neuromodulation, such as the Malpighian
tubules and hindgut, or the CNS (synganglion), respectively.  In insects, leucokinins act
through increases in intracellular calcium in a cyclic nucleotide-independent mechanism
to stimulate secretion in isolated Malpighian tubules (O'Donnell et al., 1998; Cady &
Hagedorn, 1999a; Terhzaz et al., 1999).  Leucokinins increase inositol triphosphate (IP3)
levels in isolated tubules and are thought to mediate the release of IP3 sensitive calcium
stores (Cady & Hagedorn 1999b).  Receptor binding of lymnokinin results in an increase
of intracellular calcium (Cox et al. 1997); it is therefore likely that the B. microplus
receptor induces intracellular calcium release.
Prior to our report (Holmes et al., 2000) no receptors for myokinins had been
identified from arthropods.  The characterization of myokinin receptors, such as the one
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we have cloned from the tick, is key to further understanding of the function of these
important myotropic and diuretic hormones.
The amino acid sequence of the B. microplus receptor is most similar to the
drosokinin receptor (Radford et al., 2002) and to the lymnokinin receptor from L.
stagnalis (Table 1), which has been characterized as a leucokinin-like peptide receptor
and is the first member of a new subfamily of GPCRs (Cox et al. 1997).  It is also
similar (28 % identity) to the neuropeptide Y receptor (NPY) from Drosophila (Li et al.
1992).  Prior to the characterization of the CG10626 gene product, we presented
evidence that it most likely was a myokinin receptor (Fig. 3).  The CG10626 sequence
showed higher homology to the B. microplus receptor than to the lymnokinin receptor,
as expected due to the closer phylogenetic distances between Acari (ticks and mites) and
insects than mollusks (Fig. 3). Therefore, we predicted that CG10626 was the first
known insect myokinin receptor and that its endogenous ligand was most likely the D.
melanogaster leucokinin (drosokinin) (Terhzaz et al., 1999), which was later confirmed
by its functional characterization (Radford et al., 2002).  This receptor-peptide pair may
constitute a valuable system for further testing of structure-activity relationships for the
myokinins.
The similarity between the B. microplus receptor and the drosokinin and
lymnokinin receptors is greater than that found among the subtypes of the mammalian
NPY receptor, Y1, Y2, and Y4, which are activated by the same ligand (Larhammar
1996).  Thus, the ligand for the tick receptor is most likely closely related to droskinin
(NSVVLGKKQRFHSWG-NH2) or lymnokinin (PSFHSWS-NH2), because GPCRs
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which interact with closely related ligands have the greatest sequence homology and
structural conservation (Iismaa et al. 1995; Cox et al. 1997; Terhzaz et al., 1999).
However, myokinins have not been identified in the Acari, but they have been isolated
from insects (Nässel, 1996) and the pond snail (Cox et al., 1997). There is
immunological evidence for their presence in many invertebrates, including nematodes,
molluscs and spiders (Smart et al. 1993; Elekes et al. 1994; Schmid & Becherer 1996).
It appears that leucokinin-related peptides are important neuromodulators in the CNS of
some invertebrates because of the abundance of leucokinin immunoreactive fibers in
insect brain (Nässel 1996) and the presence of lymnokinin and its receptor in the CNS of
the pond snail.  Thus, it is not unexpected that myokinin-like peptides would also occur
in ticks.  Nevertheless, cloning of this B. microplus receptor constitutes the first
indication for the presence of myokinin-type hormone signaling in the Acari (ticks and
mites).
Little is known about developmental expression or regulation of neuropeptide
receptors in arthropods.  Our finding that the tick receptor mRNA is expressed
throughout all life-stages suggests that the receptor protein may be required for critical
functions, as leucokinin receptors mediate in other invertebrates.
The lymnokinin receptor was identified as a leucokin-like peptide receptor
primarily by its mediation of leucokinin-induced intracellular calcium release (Cox et al.
1997).  This receptor was the first member of the myokinin receptor subfamily, and thus
it was not possible to identify conserved structural motifs that define this subfamily.
However, with 3 myokinin receptors now known, it is possible to make some
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comparisons. The C-terminal end of TM II (residues 103-110 in the B. microplus
receptor) and the first extracellular loop (residues 111-123) are highly conserved
between the three myokinin receptors, but not in the other neuropeptide receptor
subfamilies (Fig. 3).  Similarly, the first eight residues of the C-terminus (residues 337-
344) are highly conserved among the three myokinin receptors, and less conserved
among the other neuropeptide receptors.  These conserved regions may be useful for the
structural definition of this subfamily, or correspond to domains conferring ligand
specificity to the receptors.  It is interesting to note that TM VII is also highly conserved
among all the compared neuropeptide receptors (Fig. 3).
The B. microplus receptor has two glycosylation sites in the N-terminus, Asn 30
and Asn 41 and one in the second extracellular loop Asn 204 (Fig. 2). Multiple
glycosylation sites are found in the N-termini of several neuropeptide receptors  (Cox et
al. 1997) (Li et al. 1992) (Tensen et al. 1998a; Watson & Arkinstall 1994; Monnier et al.
1992;  Tensen et al. 1998b).  Two cysteines, Cys 348 and Cys 350 in the C-terminal
region of the B. microplus receptor are potential sites for palmitoylation, which may be
important for receptor function (Watson & Arkinstall 1994; Iismaa et al. 1995).
Receptor binding sites for peptides and protein agonists of GPCRs include the N-
terminus and extracellular loops (Gether & Kobilka 1998).  The B. microplus receptor
has several lysine (5) and arginine (4) residues in the extracellular loops, similar to
residues found in the Y1 receptors that are involved in ligand binding (Berthold &
Bartfai 1997).
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Among arthropods, ticks rank second only to mosquitoes as vectors of human
disease (Bowman et al. 1996).  The expression of tick receptor mRNA throughout all
life stages indicates that the receptor protein may be required for critical functions.  Our
discovery presents a target for the development of novel specific acaricides.  These may
prove useful to the cattle industry and in the prevention of transmission of human
diseases, such as Lyme disease.  Lyme disease is the most common vector-borne disease
in the United States, which is transmitted by closely related ixodids (Dolan et al. 1997).
GPCRs have proven to be among the most successful drug targets, and orphan or novel
receptors have great potential for drug discovery (Stadel et al. 1997).  Over 30 % of
clinically marketed drugs act on GPCRs (Wise et al., 2002).  Single treatments of
myokinins elicit a fairly long response (30 min) in insect Malpighian tubules (Terhzaz et
al. 1999).  Therefore, leucokinin receptors may be good targets for novel acaricides
because small doses could induce a prolonged physiological response.  There is a
precedent for the successful targeting of arthropod GPCRs.  Formamidines, such as
amitraz, are synthetic acaricides that act on the octopamine receptor, which is
exclusively present in arthropods (Baxter & Barker, 1999).  As all feeding stages of B.
microplus remain on the host, our discovery also presents a target for the development of
novel immunological approaches against this tick.  Vaccines against gut antigens of B.
microplus produce a protective immune response in cattle that reduces the number and
the fecundity of ticks feeding on immunized cattle (De Rose et al., 1999).
Immunoglobins cross the midgut epithelium and enter the hemolymph of many blood-
feeding arthropods without losing their immunological properties, so there is a
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possibility that many cell membrane receptors could serve as targets for vaccines (Sauer
et al., 1994).  The difficulty in exploiting this strategy has been the lack of identification
of essential tick receptors (Sauer et al. 1994).  The usefulness of the leucokinin-like
receptor for preimmunizing cattle against B. microplus can now be explored.
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CHAPTER III
FUNCTIONAL ANALYSIS OF THE Boophilus microplus
NEUROPEPTIDE RECEPTOR IDENTIFIES IT AS THE
FIRST ARTHROPOD MYOKININ RECEPTOR*
Introduction
In the last 16 years, knowledge about invertebrate neuropeptides has increased
substantially, especially in insects; dozens have been isolated and sequenced (Nachman,
2001).  However, very few peptide receptors from arthropods have been fully
characterized.  The sequencing of the Drosophila melanogaster genome (Adams et al.,
2000) revealed that approximately 200 genes code for G protein-coupled receptors
(GPCRs), and about 100 of those code for putative neurotransmitter and hormone
receptors (Brody & Cravchik, 2000).  An analysis of the Drosophila genome has
identified 44 genes that encode for peptide GPCRs (Hewes & Taghert, 2001).  Although
several insect GPCRs for neuropeptides have been identified, the majority of these are
strictly orphan receptors for which endogenous ligands have not been unequivocally
identified (Vanden Broeck, 2001).  For reviews of insect GPCRs, see Vanden Broeck
(2001) and Hewes & Taghert (2001).
At least 21 arthropod GPCRs for neuropeptides have been functionally expressed
– three for allatostatin-like neuropeptides (Birgül et al., 1999; Secher et al., 2001;
                                                
* Text and figures reprinted with permission from “Functional analysis of a G protein-coupled receptor
from the southern cattle tick Boophilus microplus (Acari: Ixodidae) identifies it as the first arthropod
myokinin receptor” by Holmes et al., 2003. Insect Molecular Biology, 12, 27-38.  Copyright 2003 by The
Royal Entomological Society.
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Auerswald et al., 2001); receptors for sulfakinin (Kubiak et al., 2002), corazonin
(Hauser et al., 1998; Cazzamali et al., 2002), proctolin (Johnson et al., 2003; Egrod et
al., 2003), FMRFamide (Cazzamali & Grimmelikhuijzen, 2002), three receptors for
neuropeptide F (DmNPF) (Garczynski et al., 2002; Mertens et al., 2002; Feng et al.,
2003), and two receptors for ecdysis triggering hormone (Iversen et al., 2002), all from
D. melanogaster; two for adipokinetic hormone from D. melanogaster and Bombyx
mori, respectively (Staubli et al., 2002); those for the corticotropin releasing factor
(CRF)-related diuretic hormone of Manduca sexta (Reagan, 1995) and the cricket
Acheta domesticus (Reagan, 1996); a receptor for tachykinin-like peptides from the
stable fly Stomoxys calcitrans (Guerrero, 1997; Torfs et al., 2000, 2001) and two from
D. melanogaster (Li et al., 1991; Monnier et al., 1992); and the tick myokinin receptor,
which is the subject of this dissertation.  The fruit fly NPY receptor although expressed,
was likely misidentified and continues to be an orphan receptor because no endogenous
ligand has been identified (Li et al., 1992; Hewes & Taghert, 2001).
 Other insect receptors that have been cloned or characterized from D.
melanogaster include one a second allatostatin receptor (Lenz et al., 2000).  The lack of
more abundant information on neuropeptide receptors limits the understanding of the
physiological processes needed for the development of new methods for control of
arthropod pests.
The myokinins or leucokinin-like peptide family are multi-functional
neuropeptides that have been found in several arthropod and invertebrate groups (Nässel,
1996).  The arthropod myokinins share the evolutionarily conserved C-terminal
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pentapeptide motif Phe-X1-X2-Trp-Gly-NH2, where X1 = His, Asn, Ser, or Tyr and X2 =
Ser, Pro, or Ala.  This amidated pentapeptide is all that is required for biological activity
(Coast et al., 1990; Nachman & Holman 1991).  Only one member of this peptide family
does not adhere strictly to this pattern, the culekinin depolarizing peptide III in which X1
= Phe (Clottens et al., 1993).  In the non-arthropod myokinins, the terminal Gly is
substituted for the Ser in lymnokinin (Cox et al., 1997) and for Ala in one of the two
shrimp kinins (Pev-kinin 2) (Nieto et al., 1998).
The myokinins have myotropic and diuretic activity in insects.  Leucokinins
stimulate hindgut contractions in the cockroach, cricket, and locust (Holman et al. 1987;
Holman et al. 1990; Schoofs et al. 1992) and increase the rate of secretion in Malpighian
tubules (Pannabecker et al. 1993; Veenstra et al. 1997; O'Donnell et al. 1998; Cady &
Hagedorn 1999b; Holman et al. 1999), also interacting with CRF-related peptides, and
serotonin in some species (O’Donnell & Spring, 2000; Pannabecker et al., 1993;
Veenstra et al., 1997; O’Donnell et al., 1998; Cady & Hagedorn 1999b; Holman et al.
1999).  In insect tissues where leucokinin signaling has been studied, myokinins were
found to act through increases in intracellular calcium (O’Donnell & Spring, 2000; Cady
& Hagedorn 1999a; Yu & Beyenbach 2002).
In addition to their effects on isolated hind guts and Malpighian tubules, there is
evidence that myokinins may have higher functions in the insect central nervous system
(CNS) as neuromodulators or neurotransmitters  (Clottens et al., 1993; Nässel, 1996).
Additionally, there is the possibility that they play a role in regulating food uptake, as
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demonstrated by their ability to decrease weight gain in H. virescens larvae (Seinsche et
al., 2000).
Interestingly, although leucokinin-like peptides have been immunolocalized in
the CNS and digestive system of the blood-feeding bug Rhodnius prolixus, they do not
appear to have a direct effect on Rhodnius Malpighian tubules (Te Brugge et al., 2001),
reinforcing the possibility of alternate functions for myokinins beyond diuresis.
Although myokinin receptors mediate this variety of function, they were
unknown in arthropods until recently.  Binding assays with Malpighian tubule
membranes from the house cricket, A. domesticus, have shown that the achetakinins
(AK) specifically bind a single class of binding sites and competitively displace an
iodinated bioactive AK-II analog (Chung et al., 1995).  Additionally, there has been one
report of the biochemical characterization of a 54-kDa leucokinin receptor from the
mosquito, Aedes aegypti (Pietrantonio et al., 2000).  The first known myokinin receptor
was cloned from the pond snail, Lymnaea stagnalis, and its endogenous ligand,
lymnokinin (PSFHSWS-NH2), was isolated by a functional intracellular calcium assay
(Cox et al., 1997).  Two receptors with homology to the lymnokinin receptor have
subsequently been identified, one which we cloned from the southern cattle tick,
Boophilus microplus (Canestrini) (Holmes et al., 2000), and one identified by the
Drosophila genome project (CG10626) (Adams et al., 2000; Radford et al., 2002).
There were no functional data available for these receptors prior to this study; however,
a neighbor-joining phylogenetic tree analysis has placed these three receptors on a single
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branch of a subgroup-specific tree of neuropeptide receptors (Hewes & Taghert, 2001).
(See also Table 2).
The southern cattle tick or cattle fever tick, Boophilus microplus (Canestrini), is
the most important tick-pest of cattle in tropical and sub-tropical regions of the world
because of its ability to transmit Babesia spp.and Anaplasma spp., the hemoparasites that
cause cattle fever (Nuñez et al. 1985).  Control of B. microplus has become increasingly
difficult worldwide because it has rapidly developed resistance to pesticides (Baxter &
Barker, 1999; Rosario-Cruz et al., 1997; He et al., 1999). One effective control strategy
for the southern cattle tick may be endocrine disruption.  Peptide hormones may have
great potential for control strategies because they are master regulators and affect a
number of physiological processes (Keeley & Hayes 1987; Nachman et al., 2002).
Therefore, myokinin receptors are potential targets for control of the cattle fever tick and
other pest species.  Our report on the cloning of the tick myokinin receptor is the first
neuropeptide from a tick species (Holmes et al., 2000).  Myokinin peptides have found
in several insects (Nässel, 1996), the pond snail (Cox et al., 1997), and the white shrimp
(Nieto et al., 1998).  Additionally there is evidence for their presence in a variety of
invertebrates, including ascarid worms (Smart et al., 1993), spiders (Schmid & Becherer,
1996), molluscs (Elekes et al., 1994), and possibly crabs (Blitz et al., 1995).
Unfortunately, to our knowledge, no neuropeptides – including myokinins – have been
isolated from ticks.  However, it is expected that myokinins are also present in ticks.
In this chapter, functional expression of the B. microplus receptor in mammalian
cells has shown that several myokinin peptides activate this receptor at nanomolar
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Table 2.  Comparison of selected neuropeptide receptors to the tick myokinin receptor.
Receptor and species Percentage
identity to tick
myokinin
receptor
E value (Blast P) Endogenous ligand
Drosokinin receptor
D. melanogaster
(Radford et al., 2002)
46.9% 2 x 10-97 Drosophila LK
NSVVLGKKQRFHSWG-NH2
(Radford et al., 2002)
Lymnokinin receptor
L. stagnalis
(Cox et al., 1997)
40.3% 2 x 10-72 Lymnokinin
PSFHSWS-NH2
(Cox et al., 1997)
Neuropeptide Y receptor
D. melanogaster
(Li et al. 1992)
28.0% 5 x 10-45 Unknown1
Tachykinin-like peptides
receptor
D. melanogaster
(Li et al., 1991)
27.2% 2 x 10-44 Unknown
Cardioexcitatory receptor
L. stagnalis
(Tensen et al., 1998)
27.5% 2 x 10-43 Lymnaea cardioexcitatory peptide
(LyCEP)
TPHWRPQGRF-NH2
(Tensen et al., 1998)
NKD tachykinin receptor
D. melanogaster
(Monnier et al., 1992)
27.0% 1 x 10-41 Unknown2
Tachykinin-like receptor
Stomoxys calcitrans
(Guerrero 1997)
29.0% 5 x 10-41 Potential ligand – Stc-TK
APTGFFAVR-NH2
(Torfs et al., 2001)3
Neurokinin 2 receptor c
Homo sapiens
(Gerard et al., 1990)
28.2% 6 x 10-41 HKTDSFVGLM-NH2
(Nawa et al., 1984)
Percentage identity is based on a multiple sequence alignment of these neuropeptide receptors with the
tick myokinin receptor protein sequence.  Sequences were aligned using the Clustal method on
DNASTAR software.  E values from Blast P searches of GenBank were scored on the BLOSUM62 matrix
and reflect the probability that sequence similarity is due to random variation rather than true homology.
1 = This receptor is activated by mammalian peptides PYY at > 30 nM and NPY at about > 90 nM when
expressed in Xenopus oocytes (Li et al., 1992) although no endogenous ligand has been identified.
2 = This receptor is activated by Locusta migratoria tachykinin although no endogenous ligand has been
identified.
3 = The natural isolated peptide sequence is as in this table, however the C-terminus consensus sequence
of the insectatachykinin group of peptides is Phe-Xxx-Gly-Xxx-Arg-NH2  (Vanden Broeck et al., 1999);
the stomoxytachykinin analog was designed with a consensus sequence.
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concentrations.  The peptide-agonist induced calcium response in these cells originated
from intracellular calcium stores.  Taken together, the results indicate that the tick
receptor is the first myokinin receptor to be cloned from an arthropod.
Methods
Expression construct
The cloning of the cDNA for the myokinin peptide receptor (AF228521) from larvae of
the southern cattle tick, B. microplus, was described in the first chapter.  The coding
region of the receptor cDNA was amplified by PCR using primers modified to
incorporate a 5’ Kozak consensus sequence (GCC A/G CC ATG G) around the
presumed start codon for optimal ribosomal binding in a mammalian system (Kozak,
1986) and restriction sites (5’ primer XhoI, 3’ primer BamHI) for unidirectional cloning.
The primers were BM3.2 sense primer, 5’-TTC CTC GAG GGT GCC ACC ATG GCC
T, and BM3.2 anti-sense primer, 5’-T AGG ATC CCA CTG GTG GTT GGA CTC
(modified base pairs and restriction sites in bold).  The modification of the first base pair
following the start codon (G instead of A in the original sequence) is expected to change
the second residue of the expressed protein from the threonine (T) of the native sequence
to an alanine (A).  The modified sequence was cloned into the XhoI/BamHI sites of
mammalian expression vector pcDNA3.1(-) (Invitrogen, Carlsbad, CA), which includes
the cytomegalovirus promoter and the neomycin resistance gene.  The accuracy of the
expression construct was verified by sequencing.
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Cell culture and transfection
CHO-K1 cells were maintained in Kaighn’s modification of Ham’s F-12 medium
(Life Technologies, Gaithersburg, MD) supplemented with 10% fetal bovine serum
(EquiTech Bio, Kerrville, TX) in a humidified incubator with 5% CO2 at 37° C as
recommended by ATCC (ATCC Product Information Sheet, Manassas, VA).  For
transfection, CHO-K1 cells were seeded into 60-mm tissue culture plates and allowed to
grow 24-48 h until 30-50% confluent.  Cells were transfected in serum free Opti-MEM
medium (Life Technologies) with the cationic lipid reagent Lipofectin® (Life
Technologies) (6 µl) and 2 µg of the expression construct or the empty vector (for
negative control) according to the manufacturer’s protocol.    A preliminary dose-
response assay with untransfected cells against the antibiotic GENETICIN® G-418 (Life
Technologies) was conducted to determine the concentration necessary to select for
stably transfected cells.  All untransfected cells died after ten days at a concentration of
700 µg/ml.  Thus, 800 µg/ml GENETICIN® was used to generate stable transfectants by
continuous selection for 14 days, which were thereafter maintained in media containing
400 µg/ml GENETICIN® (Anonymous 1999).
Isolation and screening of stably transfected clones
After antibiotic selection, four stably transfected clonal cell lines were isolated
by serial dilution of cell suspensions across 96-well tissue culture plates beyond a
limiting dilution (theoretically less than 1 cell per well).  After 2-3 days of growth, the
plates were examined and wells with a single colony that appeared to result from the
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deposition of a single cell were selected.  After single cell colonies had grown to 50-100
cells, they were trypsinized and replated in a 96-well plate and allowed to grow an
additional 2-3 days until confluent.  Trypsinization and growth was repeated with
sequentially larger cell culture plates until there were enough cells to start T-25 cell
culture flasks (approximately 200,000 cells).  Cells were harvested from T-25 flasks for
transcription analysis.  Total RNA was isolated from transfected cell lines with TRIzol
Reagent (Life Technologies) according to the manufacturer’s protocol.  First strand
cDNA was synthesized from approximately 1.3 µg of total RNA from each sample at
42° C for 50 min with a gene-specific anti-sense primer SC3-R (5’-TG GTG GTT GGA
CTC AAA TTA CAC, AF228521 base pairs 1283-1304) using SuperScript II Reverse
transcriptase (SuperScript First-Strand Synthesis System for RT-PCR, Life
Technologies).  PCR amplification of the entire open-reading frame (ORF) of receptor
cDNAs was performed with gene-specific primers (BM3.2 and SC3-R), corresponding
to sequence flanking the 5’ and 3’ ends of the ORF, respectively, with an expected
product size of 1227 bp.  Reactions contained one-tenth (2µl) of the synthesized cDNA,
200 µM each of four dNTPs, 0.2 µM of each primer, 1 µl Taq polymerase, and 1X
reaction buffer (Boehringer Mannheim) in a final volume of 50 µl.  The following
cycling parameters were used: 94°C for 1 min followed by 35 cycles of 94°C for 30 s,
55°C for 30 s, and 72°C for 1 min, followed by a final extension step of 72°C for 5 min.
cDNA from control RNA (SuperScript First Strand Synthesis System for RT-PCR)
was synthesized and amplified under identical conditions with gene-specific primers
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provided by the manufacturer with an expected product size of 500 bp.  Ten µl of each
reaction was electrophoresed on a 1% TBE agarose gel containing ethidium bromide,
then photographed.  Cell lines positive for receptor transcript were challenged with a
single dose (10 µM) of lymnokinin (PSFHSWS-NH2) and intracellular calcium
responses were monitored as described below.  A single clonal cell line that responded to
lymnokinin challenge with an increase in intracellular calcium was selected for the
assays described in this chapter.  Cells transfected with expression vector only were
subjected to the same selection conditions until resistance to GENETICIN was
acquired.
Peptide synthesis and purification
Muscakinin (NTVVLGKKQRFHSWG-NH2) was synthesized and purified as
previously described (Holman et al., 1999).  Lymnokinin (PSFHSWS-NH2), the
stomoxytachykinin analog APTGFFGVR-NH2 (Torfs et al., 2001), and insect kinin
analog FFFSWS-NH2 were synthesized using solid phase FMOC protection chemistry
on Rink Amide resin (0.4 meq/gm; Novabiochem, San Diego, CA) on an ABI 433A
Peptide Synthesizer (PE Biosystems, Foster City, CA) according to previously described
conditions (Nachman et al., 1997).  Side chain protection used was as follows:
Arg(Pmc), His(Trt), Ser(tBu), Thr(tBu) and Trp(Boc).  The peptide was cleaved from
the resin complex with a mixture of trifluoroacetic acid (TFA)(90%), anisole (5%),
thioanisole (4%), and ethanedithiol (1%) for 1.5 h at room temperature.  The resin was
filtered and volatile reagents were removed in vacuo on a Savant Speed Vac
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concentrator at 40°C.  The products were purified on a Waters C18 Sep Pak cartridge and
a Delta Pak C18 reverse-phase column (8 x 1-00 mm, 15 µm particle size, 100 Α pore
size) on a Waters Model 510 HPLC controlled with a Millennium 2010 chromatography
manager system (Waters, Milford, MA) with detection at 214 nm at ambient
temperature.  Solvent A = 0.1% aqueous TFA; Solvent B = 80% aqueous acetonitrile
containing 0.1% TFA.  Conditions:  Initial solvent consisting of 20% B was followed by
the Waters linear program 6 to 100% B over 40 min; flow rate, 2 ml/min.  Delta Pak C18
retention times: lymnokinin, 7.5 min; stomoxytachykinin analog APTGFFGVR-NH2, 9
min; insect kinin analog FFFSWS-NH2, 15 min.  The analogs were further purified on a
Waters Protein Pak column (Milligen Corp., Milford, Ma).  Conditions: Solvent A= 95%
aqueous acetonitrile made to 0.01% TFA; Solvent B = 50% aqueous acetonitrile made to
0.01% TFA; 100% A isocratic for 4 min followed by a linear program to 100% B over
80 min.  WatPro retention times: lymnokinin, 10.5 min; stomoxytachykinin analog
APTGFFGVR-NH2, 10.25 min; insect kinin analog FFFSWS-NH2, 6.0 min.  MALDI
mass spectra were obtained on a Kratos Kompact probe MALDI instrument (Kratos,
Manchester, UK) with alpha-cyano-4-hydroxycinnamic acid as a matrix.  The structural
identity was confirmed by the presence of the following molecular ions (MH+):
lymnokinin, 845.6 (Calc. MH+: 845.38); stomoxytachykinin analog APTGFFGVR-NH2,
949.6 (Calc. MH+: 949.51); insect kinin analog FFFSWS-NH2, 841.6 (Calc. MH+:
841.37).  The peptides were quantified via amino acid analysis as previously described
(Nachman et al., 1997).  All other peptides (the insect kinin analogs FFFSWG-NH2,
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FFSWG-NH2, and FYSWG-NH2) were synthesized and purified as previously described
(Pietrantonio et al., 2000).
Peptides were solubilized in 80% acetonitrile with 0.01% trifluoroacetic acid (TFA), and
aliquots for use were dried down then resuspended in Dulbecco’s Modified Eagle’s
medium with F-12 salts without serum or phenol red (Life Technologies).
Analysis of peptide activity through intracellular Ca2+ measurement
Approximately 80,000 cells were seeded in 2-well Lab-Tek Chambered
Coverglass slides (Nalge Nunc, Naperville, IL) 48 hours prior to assays and grown to
approximately 80% confluence.  A stock solution of 1 mM fluo-4 AM (Molecular
Probes, Eugene, OR), a Ca++-sensitive fluorophore, was prepared in dimethyl sulfoxide
(DMSO) and diluted with serum- and phenol red-free Dulbecco’s Modified Eagle’s
medium with F-12 salts (DMEM F-12) to a 3 µM solution (0.3% final DMSO
concentration) for loading cells.  Cells were loaded for one hour with fluo-4 AM after
which the monolayer was washed once with fresh medium prior to challenge with
peptide agonists. The range of agonist concentration expected to be effective in assays
was from 10-10 M to 10-5 M, the range that has been shown to effect changes by
neuropeptides in isolated Malpighian tubules of the mosquito Aedes aegypti (Veenstra et
al., 1997; Pietrantonio et al., 2000) and the desert locust Schistocerca gregaria (Coast et
al., 1999).  Therefore, kinin peptides were first tried at a high concentration of 10 µM
followed by lower doses until a response was no longer observed.  Negative control cells
transfected with vector only were challenged with high concentrations (10 µM) of
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lymnokinin under identical conditions.  Agonist induced changes in intracellular Ca++
were monitored with a Meridian Ultima Confocal Microscope (Meridian Instruments,
Okemos, MI) at the Image Analysis Laboratory, College of Veterinary Medicine, Texas
A&M University.  Cells were placed on the stage of the confocal microscope, and an
area of the chamber slide was selected for analysis.  For image collection, scan
parameters were adjusted for maximum detection of fluorescence with minimum cellular
photobleaching.  Fluorescence was generated in the cells by excitation at 488 nm, and
fluorescence emission of 530 nm was collected from individual cells by means of a
photomultiplier tube.  Initial basal fluo-4 fluorescence intensity was obtained from 5
image scans recorded from about 8-25 selected cells every 3 seconds.  After the fifth
scan, cells were exposed to peptide agonists resolubilized in DMEM F-12 media, and
image scans were acquired at the same interval for a total time of 300 seconds.  Negative
control experiments were performed in an identical fashion with the addition of media
containing no peptides.
Analysis of signal transduction
To analyze the mechanism of myokinin signal transduction it was necessary to
establish a typical positive curve in CHO-BMLK3 cells.  Thus, cells were assayed
against 10 µM lymnokinin or 100 nM FFFSWG-NH2, the latter chosen because of its
high potency in the intracellular calcium assay described above and its strong
depolarizing activity on mosquito Malpighian epithelium (Pietrantonio et al., 2000).   As
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a negative control, CHO-BMLK3 cells were challenged with 100 nM of the unrelated
peptide hormone oxytocin (Sigma) (Table 3).
To check the contribution of extracellular and intracellular sources of calcium to
myokinin induced responses, CHO-BMLK3 cells were co-treated with thapsigargin, an
inhibitor of the microsomal Ca2+-ATPase that also produces an outward passive leak of
Ca2+ from intracellular stores (Hofer, 1999), or EGTA, used as an efficient chelator for
extracellular calcium ions (both obtained from Sigma, St. Louis, MO).  Thapsigargin (1
µM final concentration; prepared in 0.1% DMSO) was added after scan number 14,
about 30 s after the addition of lymnokinin and the occurrence of the expected peak in
fluorescence.  The respnse to thapsigargin would allow us to determine if lymnokinin
produced a maximal cellular response, characterized by the complete depletion of
intracellular calcium stores.
To determine if extracellular calcium is required for the initial intracellular
fluorescence response to myokinins, EGTA (1mM) was added to media about 1 min
prior to the first scan; the analog FFFSWG-NH2 was added after the fifth scan.
To investigate the tick receptor interaction with G proteins, cells were pretreated
with concentrations of pertussis toxin (Sigma) from 50 ng/ml to 1000 ng/ml for 16 hours
prior to peptide analog challenge.  For these assays, FFFSWG-NH2 was added after the
fifth scan (approximately 15-18 s).
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Statistical analysis
Intracellular calcium concentration was expressed in relative fluorescence
intensity units (FIU).  Four samples per concentration were analyzed, each sample
representing from 8-25 cells.  For each cell, fluorescence data were normalized by
dividing the value from each scan by the value from the first scan (basal fluorescence).
For each cell, log transformation was done on normalized data (ratios) when used for
statistical analysis.  Traces correspond to either the raw or normalized FIU as indicated,
and vertical lines correspond to the standard error of four samples.  Student’s T-test and
the Dunnett’s Multiple Comparison test were used to determine the level at which
agonist induced fluorescence peak values were significant above controls.
Estimation of EC50 values and their respective 95% confidence intervals (Table
3) was done using nonlinear regression sigmoidal-dose response curve fitting (GraphPad
Software, San Diego, CA).  Briefly, the maximum normalized intensity values (Fig. 7,
black bars in histograms) for the log of each concentration were used to fit a non-linear
equation that calculated the corresponding log concentration on the x axis (log EC50s)
using the 50% maximal FIU.  EC50s and confidence intervals were converted from log
values for presentation in Table 3.  Analogues with overlapping confidence limits for the
EC50 were considered of similar activity.
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Results
Isolation of the clonal cell line CHO-BMLK3 expressing the B. microplus receptor
Four clonal cell lines transfected with the receptor construct were isolated
following antibiotic selection.  RT-PCR with primers corresponding to sequences
flanking the coding region of the receptor revealed that only two of the cell lines,
designated CHO-BMLK2 and CHO-BMLK3, were transcribing receptor mRNA (data
not shown).  These two cell lines and a cell line only transfected with expression vector
were challenged with 10 µM lymnokinin.  Only the cell line CHO-BMLK3 showed an
increase in intracellular calcium upon challenge (Fig. 6), indicating that the other cell
line was not properly expressing the receptor protein.  Therefore, the CHO-BMLK3 cell
line was chosen for further study.  Figure 6 shows the raw fluorescence data (not
normalized) of a typical assay.  The top trace in Fig. 6 is typical of this cell line’s
response to challenge with high concentrations of myokinins.  The application of
lymnokinin to the cells after 5 scans (Fig. 6, arrow) resulted in a rapid rise in
intracellular calcium that was maintained at a high level for longer than 5 min.  As
expected, cells transfected with vector only showed no response to lymnokinin.
In the following figures, except Fig. 8B, data were normalized to values obtained
from the first scan (taken prior to agonist challenge) to account for differences in basal
fluorescence between respective samples (see Methods).
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Figure 6.  Typical response of CHO-BMLK3 (n=14) and CHO-pcDNA cells (n=12)
to 10 µM lymnokinin (PSFHSWS-NH2).  Introduction of lymnokinin at 15-18
seconds (arrow) resulted in a rapid elevation of intracellular calcium as shown by
fluo-4 AM fluorescence in CHO-BMLK3 only.  Control cells CHO-pcDNA,
transfected with vector only, showed no response to lymnokinin.
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Receptor mediated response to myokinin peptides
The natural peptides lymnokinin and muscakinin were chosen for assays because
of their efficacy in a functional calcium assay (Cox et al., 1997) and in the house fly
Malpighian  tubule secretion assay (Holman et al., 1999; Coast, 2001) respectively.  The
myokinin analogs FFFSWG-NH2, FFSWG-NH2, and FYSWG-NH2 have previously
been shown to cause depolarization and stimulate fluid secretion in the mosquito
Malpighian tubule (Pietrantonio et al., 2000; Hayes et al., 1989).  The analog FFFSWS-
NH2 was designed to investigate the effect of replacing the terminal Gly with Ser, a
substitution in the myokinin peptide family unique to lymnokinin (Table 1 in
Pietrantonio et al., 2000).  Each of the myokinin peptides tested in the functional
calcium assay resulted in a dose-dependent rise in intracellular calcium (Figure 7A-F).
High concentrations of peptide resulted in a rapid increase in intracellular calcium,
which was then maintained for the duration of the assay.  Lower concentrations induced
peaks of varying intensity, which were not followed by sustained levels of fluorescence.
An agonist for the related tachykinin receptor (STKR) from the stable fly
(APTGFFAVR-NH2, Torfs et al., 2001) induced a weak response only at a 40 µM, the
highest concentration tested.  This concentration was approximately 1000-fold higher
than concentrations of synthesized natural myokinins (lymnokinin, muscakinin) (Fig.
7G, Table 3) and approximately 4000-fold higher than concentrations of the least potent
myokinin analog required to induce a similar response (Fig. 7G).
A curve-fitting analysis was used to estimate the EC50 for each myokinin peptide.
The designed hexamers FFFSWS-NH2 and FFFSWG-NH2 were the most potent,
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followed by the pentamers FFSWG-NH2 and FYSWG-NH2 (Table 3).  Of the myokinins
tested, muscakinin and lymnokinin were the least potent, with muscakinin nearly as
potent as the artificial pentamers (EC50 = 17.02 nM) and lymnokinin about 43-fold less
potent (EC50 = 566 nM) than the weakest pentamer.  As expected the STKR agonist was
much less potent than the myokinins, indicating the selectivity of this receptor for
leucokinin-like peptides.  Similarly, there was no response to 100 nM oxytocin (Fig.
8A), indicating that the response was specific to myokinins and could not be induced by
an unrelated peptide hormone.
Signal transduction analysis
The absence of extracellular calcium ions did not have any detectable effect on
the calcium response induced by myokinin agonists.  In the presence of 1 mM EGTA, a
chelator of calcium ions, the response of CHO-BMLK3 cells to 100 nM FFFSWG-NH2
was unaffected, indicating that initial receptor-mediated increases in intracellular
calcium are the result of release from intracellular stores (Fig. 8A).  This was confirmed
by an assay in which cells were first challenged with 1 µM lymnokinin 15-18 s after
scans began and then 1.0 µM thapsigargin at 42-45 s (Fig. 8B).  Treatment with
thapsigargin, would have increased calcium levels by releasing any remaining calcium
ions from a single pool of intracellular stores.  Thapsigargin failed to further increase the
calcium levels of transfected cells, indicating that internal stores the affected pool had
already been depleted by treatment with lymnokinin and that at this concentration,
lymnokinin produced a maximal response.
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Figure 7.  Response of CHO-BMLK3 cells to myokinins, myokinin analogs, and a tachykinin analog.  DMEM
F-12 media containing 10X final concentration of each peptide (100 µl) was added to cells for a final volume of
1 ml.  Control was addition of 100 µl media without peptides.  Fluo-4 AM fluorescence intensity was obtained
from image scans recorded from about 8-25 cells every 3 seconds.  After the fifth scan (15-18 seconds), cells
were exposed to peptide agonists and image scans were acquired at the same interval for a total time of 300
seconds.  Each concentration was replicated four times.  Data presented is normalized fluorescence units.
Histograms represent peak fluorescence levels of each concentration.  The lowest concentration with a
statistically significant (p < 0.05) peak over the corresponding control is marked with an asterisk (Student’s T-
test and Dunnett’s Multiple Comparison test).  Traces correspond to the mean fluorescence at each scan
measured from the 8-25 individual cells of four replications.  A)  Response to FFFSWS-NH2.  B)  Response to
FFFSWG-NH2.  C)  Response to FFSWG-NH2.  Trace for 0.0001 µM not shown.  D) Response to FYSWG-
NH2.  Trace for 0.00001 µM not shown. E)  Response to muscakinin (NTVVLGKKQRFHSWG-NH2).  F)
Response to lymnokinin (PSFHSWS-NH2).  Traces for 0.05 and 0.01 µM not shown.  G) Response to S.
calcitrans tachykinin-like peptide receptor (STKR) agonist (APTGFFGVR-NH2).  Traces for 10 and 20 µM not
shown. In C, D, F and G, traces not shown were indistinguishable from the respective control trace.
*
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Figure 7. Continued.
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Figure 7. Continued.
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Figure 7. Continued.
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Figure 7. Continued.
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Table 3.  Amino acid sequence and estimated potencies (EC50s ± 95 % confidence intervals)
of myokinin peptides and designed analogs in inducing a calcium response in receptor transfected cell line
CHO-BMLK3.  EC50s are an estimate of the concentration required to induce a half-maximal response.
EC50s followed by similar letters in superscript are not significantly different.
Peptide EC50 ± C.I.
FFFSWS-NH2   4.2 ± 1.7 nMA
FFFSWG-NH2   5.7 ± 2.1 nMAB
FFSWG-NH2   8.4 ± 2.4 nMB
FYSWG-NH2 13.1 ± 2.1 nMC
Muscakinin
NTVVLGKKQRFHSWG-NH2
17.0 ± 1.6 nMD
Lymnokinin
PSFHSWS-NH2
 566 ± 1.5 nME
STKR agonist
APTGFFGVR-NH2
Not estimated
(> 20 µM)
Oxytocin
CYIQNCPLGG-NH2
No response
 Pertussis toxin is an AB5 protein homologous to cholera toxin that ADP-
ribosylates a specific Cys residue of Gi∝.  The modified G-protein does not exchange its
bound GDP for GTP (Fields & Casey, 1997).  Pretreatment of transfected cells with
concentrations of pertussis toxin up to 1000 ng/ml for 16 h prior to agonist challenge did
not inhibit the cellular response to FFFSWG-NH2 (Fig. 8C), indicating  that myokinin
peptides exert their effects through a pertussis toxin-insensitive G protein mediated
pathway in mammalian CHO-K1 cells.
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A
Figure 8.  Analysis of signal transduction.  A) Response of CHO-BMLK3 cells to 100 nM FFFSWG-NH2 in
comparison to cells co-treated with this peptide and 1 mM EGTA (EGTA added 1 min prior to peptide).
EGTA had no significant effect.  Cells did not respond to 100 nM of the unrelated mammalian peptide hormone
oxytocin.  B)  Response of CHO-BMLK3 cells to 1 µM lymnokinin followed by 1 µM thapsigargin.  Trace
represents the raw fluorescence mean response of 16 cells.  Lymnokinin was added at 15 seconds (first arrow)
and thapsigargin at 42 seconds (second arrow).  Thapsigargin treatment did not increase fluorescence indicating
that lymnokinin treatment had depleted intracellular calcium stores. C) Response of CHO-BMLK3 cells to 1
µM thapsigargin followed by 1 µM lymnokinin. Thapsigargin was added at 15 seconds (first arrow) and
lymnokinin at 90 seconds (second arrow). D) Response of CHO-BMLK3 cells to 100 nM FFFSWG-NH2 in
comparison to untreated cells (control) and cells pretreated with 50-1000 ng/ml pertussis toxin for 16 hours.
Although only the traces for 50 and 500 ng/ml pertussis toxin are shown, this toxin in concentrations up to
1000 ng/ml did not significantly inhibit the calcium response.
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B
C
Figure 8. Continued.
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D
Figure 8. Continued.
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Discussion
Our study shows that the tick receptor, when stably expressed in a CHO-K1 cell
line, mediates agonist-induced changes in intracellular calcium as a second messenger in
response to nanomolar concentrations of myokinins.  This study proves that the tick
receptor (AF228521) is the first myokinin receptor to be cloned from an arthropod.
The rank-order of potency for the peptides tested was FFFSWS-NH2 ≥ FFFSWG-NH2 ≥
FFSWG-NH2 > FYSWG-NH2 > muscakinin > lymnokinin.  This corresponds to the
ranking found with some of these peptides in a transepithelial voltage (T.V.) assay in
Aedes Malpighian tubule, where FFFSWG-NH2 > FFSWG-NH2 > FYSWG-NH2
(Pietrantonio et al., 2000), although EC50s for these three peptides were lower than we
found in this study.  Veenstra et al. (1997) also found that Aedes leucokinins 1-3
depolarized the Aedes Malpighian tubule at very low concentrations, with EC50s ranging
from 2.5 x 10-11 M to 3.9 x 10-10 M.
In contrast, higher concentrations of Aedes leucokinins 1 and 3 (10-8 to 10-6 M ) were
required to stimulate fluid secretion from the tubules, while Aedes leucokinin 2 had no
effect on tubule secretion (Veenstra et al., 1997).  This difference between myokinin
concentrations required for the observed effects, where approximately 100 times greater
concentrations are required for secretion, may account for the wide range of effective
concentrations reported by Pietrantonio et al. (2000), but not seen in our assay with the
same myokinin analogs.  The myokinin analog FYSWG-NH2, which is identical to the
terminal pentapeptide sequence of Aedes leucokinin 1, had an EC50 for fluorescence
response on the order of 10-8 M and ranked fourth in our assays. This EC50 is closer to
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the concentration of Aedes leucokinin 1 required to stimulate fluid secretion than that
required to depolarize the T.V. in mosquito Malpighian tubules.  In summary, our results
appear to indicate that potencies estimated from T.V. assays may not be good indicators
of myokinin physiological response – such as diuretic activity - because depolarization
can be induced at much lower concentrations and is not always associated or causative
of fluid secretion.
Although lymnokinin was not highly potent in our assay (EC50 = 566 nM), this
was not unexpected because it is not known to be an endogenous tick peptide.  In a
similar assay with CHO-K1 cells expressing the lymnokinin receptor, lymnokinin and
the synthetic peptide PSFHSWG-NH2, identical to lymnokinin except for the Gly
residue, induced increases in intracellular calcium.  Both peptides had a similar potency
(lymnokinin EC50 = 1.14 nM) (Cox et al., 1997).  Similarly we found that exchanging
the terminal Ser for Gly did not significantly affect the potency on the tick receptor,
since the peptides FFFSWG-NH2 and FFFSWS-NH2 had similar potencies.  It appears
that in the snail and tick, these two residues are interchangeable at the C-terminus.
However the C-terminal Gly is conserved in all the known insect myokinins, suggesting
that it is necessary for myokinin action in insects.  In support of this, an alanine scan of
the peptide FYSWG-NH2 revealed that replacement of the Tyr (Y) or Gly (G) residues
made the peptide about 1/20 as effective in causing contractions of the roach hindgut
(Nachman & Holman, 1991).  The high conservation of the C-terminal Gly in the insect
myokinins could thus indicate evolutionary differences in insect receptors.  An
interesting test would be to compare the effects of these two peptides in an insect
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receptor expression system to determine if the results support those found with isolated
tissues by Nachman & Holman (1991) mentioned above.
The natural myokinins have 1 to 10 variable N-terminal residues beyond the
pentapeptide core which affect potency (Holman et al., 1991; Coast et al., 2002).  Cox et
al. (1997) also determined that leucokinins IV and VI (DASFHSWG-NH2 and
pESSFHSWG-NH2, respectively) were about 1/100 as potent in eliciting a calcium
response than lymnokinin, although their C-terminal pentapeptide sequence is identical
to lymnokinin except that the C-terminus is Gly instead of Ser.  However in our assay,
muscakinin, which has a similar terminal pentapeptide sequence to lymnokinin, was
approximately 30-fold more potent than lymnokinin.  As discussed, the C-terminus
substitution of Gly with Ser does not seem to significantly affect activity on the tick
receptor, so the difference in activity between peptides with identical cores (except for G
or S) and different N-terminal residues observed by us and by Cox et al. (1997), is most
likely due to the effect of these variable N-terminal residues.  In agreement with this,
achetakinin-V (AFHSWG-NH2) is 10-fold more potent than the core peptide FHSWG-
NH2 in inducing diuretic responses in isolated Malpighian tubules from the house
cricket, A. domesticus (Coast et al., 1990).  The critical role of N-terminal residues in
peptide activity was demonstrated by Coast et al., (2002), who showed that the
pentapeptide minimum active sequence of muscakinin was less potent than muscakinin
by more than five orders of magnitude in the house fly Malpighian tubule secretion
assay.
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The response of CHO-BMLK3 cells to 100 nM FFFSWG-NH2 was unaffected
by the presence of 1 mM EGTA (Fig. 8A), indicating that calcium ions involved in
receptor mediated signal transduction were released from intracellular stores, as was also
found in the stellate cells from Drosophila Malpighian tubule (Rosay et al., 1997).
Treatment with thapsigargin following challenge with 1 µM lymnokinin failed to cause
any further increase in intracellular calcium, indicating that intracellular stores were
depleted by myokinin receptor maximal activation (Fig. 8B).  Lack of inhibition of the
myokinin-induced calcium response by pertussis toxin indicates that the signal
transduction is effected through a pertussis toxin-insensitive G protein (Fields & Casey,
1997).
After the drosokinin and lymnokinin receptors, tachykinin receptors are the most
similar in sequence to the tick receptor (Table 2).  Therefore, observed reduced response
elicited by high concentrations of a tachykinin-like peptide (Fig. 7G) demonstrates the
high selectivity of the receptor for myokinins.  The strong activity of muscakinin on the
tick receptor (EC50 = 17 nM) indicates that its endogenous ligand may be a similar
peptide.  Muscakinin is identical - except for one amino acid substitution - to a myokinin
peptide (drosokinin) isolated from D. melanogaster (Terhzaz et al., 1999).  Because the
GPCRs that interact with closely related ligands also have the greatest sequence
homology and structural conservation (Iismaa et al., 1995), we predicted  that CG10626,
the Drosophila gene product now known as the drosokinin receptor, would have a
closely related ligand that was most likely the drosokinin peptide (Holmes et al., 2003).
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Based on homology with other receptors, the tick receptor was expected to
belong to the subfamily of myokinin receptors (Homes et al., 2000; Hewes & Taghert,
2001).  Our functional assays with the tick receptor have unequivocally established it as
the first myokinin receptor identified from an arthropod, as well as the first neuropeptide
receptor cloned from an arachnid.  Although this receptor remains an orphan because no
endogenous ligand has been isolated, its specificity for myokinins is clear.  This
receptor’s reponse, the leucokinin-like immunoreactivity found in the spider (Arachnida)
nervous system (Schmid & Becherer, 1996), and the detection of receptor mRNA in all
life stages of the tick (Chapter II), indicate that myokinin peptides may play a critical
role in the physiology of the tick.  Myokinin receptors have been validated as novel
targets for pest control in the cotton budworm Heliothis virescens.  Larvae injected with
helicokinins I increased mortality, as well as when  co-injected with helicokinins II or III
and an angiotensin-converting enzyme inhibitor (Seinsche et al., 2000).  The functional
expression of the tick receptor makes available a system for screening compounds for
agonist or antagonist activity.
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CHAPTER IV
TISSUE DISTRIBUTION AND IMMUNOLOGICAL
CHARACTERIZATION OF THE TICK MYOKININ RECEPTOR
Introduction
Relatively little is known of the expression and function of myokinin receptors in
invertebrate organisms, despite their important roles in physiological processes of
insects, including diuresis.  This is not surprising considering that descriptions of only
three myokinin receptors from the pond snail Lymnaea stagnalis (Cox et al., 1997),
cattle tick Boophilus microplus (Holmes et al., 2000; Holmes et al., 2002), and fruit fly
Drosophila melanogaster (Radford et al., 2002), respectively are recently available in
the published literature.  In contrast, much more is known of the myokinin neuropeptides
that are the endogenous ligands.  With the isolation of the Drosophila leucokinin,
drosokinin (Terhzaz et al., 1999), there are now 26 known members of the myokinin
peptide family.  The first members of this family, the leucokinins I and II, were isolated
and described in 1986 (Holman et al., 1986a).
In insects, the myokinin peptides increase the frequency of hindgut contractions
and stimulate secretion from the Malpighian tubules.  The leucokinins were initially
isolated on the basis of their ability to stimulate hindgut contractions in the cockroach
Leucophaea maderae (Holman et al., 1986a; Holman et al., 1986b; Holman et al.,
1987a; Holman et al., 1987b).  Related myokinins from the locust Locusta migratoria
(Schoofs et al., 1992), mosquito Aedes aegypti (Veenstra et al., 1997), and the house fly
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Musca domestica (Holman et al., 1999) have been shown to stimulate hindgut
contractions in those species.  In the crab Cancer borealis, leucokinins excite the pyloric
rhythm (Blitz et al., 1995).  In the Malpighian tubules, the myokinins act through
increases in intracellular calcium to stimulate fluid secretion (Cady & Hagedorn, 1999b;
O’Donnell & Spring, 2000; Yu & Beyenbach, 2000).
Both the lymnokinin receptor and peptide were isolated from the CNS of the
pond snail L. stagnalis (Cox et al., 1997), indicating expression in nervous tissue.
Leucokinin-like immunoreactivity has consistently been found in the nervous system of
several arthropod groups, including the brain and ventral ganglia of L. maderae (Nässel,
1992), abdominal ganglia of the tobacco hornworm, Manduca sexta (Chen et al., 1994),
brain and thoracic ganglia of the mosquito Culex salinarius (Clottens et al., 1993), brain
and fused thoracic-abdominal ganglion of M. domestica (Iaboni et al., 1998), CNS and
digestive system of the blood-feeding bug Rhodnius prolixus (Te Brugge et al., 2001),
the CNS and leg neuromeres of the spider Cupiennius salei (Schmid & Becherer, 1996),
and the CNS of the flies D. melanogaster, Calliphora vomitoria, and Phormia
terraenovae (Cantera & Nässel, 1992).  Additionally, two myokinin-related peptides
have been isolated from the brain of the white shrimp Penaeus vannamei (Nieto et al.,
1998).
The first localization of a myokinin receptor was of the D. melanogaster
drosokinin receptor (Radford et al., 2002), previously identified by the Drosophila
genome project as gene product CG10626.  Immunohistochemistry showed expression
of this receptor in the stellate cells of the Malpighian tubules and pars intercebralis of the
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adult CNS.  Receptor transcript was additionally found by RT-PCR in the male and
female gonads (Radford et al., 2002).  In the cricket Acheta domesticus and mosquito A.
aegypti, myokinin binding sites have been biochemically characterized in the
Malpighian tubules, and presumably correspond to myokinin receptors in those species
(Chung et al., 1995), (Pietrantonio et al., 2000).  Despite the strong possibility of
myokinin receptor expression in the invertebrate brain, receptor localization efforts have
focused mainly on the Malpighian tubules and digestive systems where their functions
are best understood.
In this chapter, receptor transcripts were detected by RT-PCR in the dissected
synganglion, gut, salivary glands, ovaries, and Malpighian tubules of partially engorged
B. microplus adult females.  This is the first evidence of myokinin receptor expression in
the salivary glands and in non-nervous tissue in an arachnid.  Rabbit anti-receptor
antisera directed against a synthetic peptide corresponding to the predicted second
extracellular loop of the B. microplus receptor was generated in two rabbits.
Immunolocalization experiments were performed in order to determine if the antisera
contained antibodies that would effectively bind receptor proteins and be useful for
immunohistochemistry.  Functional experiments with the anti-receptor antisera were
performed to determine if antibody binding of the second extracellular loop would
inhibit agonist induced activity.  These experiments did not show that the antisera was
able to specifically bind the receptor protein or inhibit function.
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Methods
Production of antisera/antibodies
Both whole antisera and affinity-purified sera directed against the tick receptor
were used in experiments.  Receptor antisera were produced by Sigma Genosys (The
Woodlands, TX) in two female New Zealand rabbits by a standard ten-week protocol.
The synthetic peptide RVETQVESHALNLTKC was linked to keyhole limpet
hemocyanin (KLH) and used to immunize the rabbits six times to boost antibody
production.  The first immunization contained 200 µg of the KLH-conjugate in
Complete Freund's Adjuvant, and subsequent immunizations contained 100 µg in
Incomplete Freund's Adjuvant.  The synthetic peptide corresponds to the partial
sequence from the predicted 2nd extracellular loop of the receptor, except for the terminal
Cys which was added to facilitate C-terminal linking to KLH.  Serum was collected in a
preimmune bleed, four production bleeds, and a final exsanguination.  Antisera were
preserved with 0.1% sodium azide, and stored at -80˚C in 1 ml aliquots until use.
Commercially prepared rabbit anti-integrin β5 subunit polyclonal antibody (Chemicon
International, Temecula, CA) was used as a positive marker for the presence of plasma
membrane proteins in western blots.
Affinity purification of antisera
To produce an affinity column for purification of anti-receptor peptide
antibodies, approximately 6 mg of synthetic peptide was linked to Affi-Gel® 10
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activated immunoaffinity support (Bio-Rad, Hercules, CA).  Residual water was
removed from the hygroscopic solvents DMSO and triethylamine by storing them over 4
Å molecular seives for a minimum of 48 h ("drying").  A 10 ml aliquot of
immunoaffinity support was prepared by removing the storage solvent (isopropanol) and
washing with “dry” DMSO.  Solvents were removed by filtering with suction through a
layer of Whatman 3M paper over a fritted funnel.  The support was combined with
synthetic peptide in 20 ml of dry DMSO, 100 µl of triethylamine was added, and the
mixture was incubated overnight (16 h) at RT with gentle agitation.  The mixture was
incubated an additional hour at RT after the addition of 500 µl of ethanolamine, after
which the solvent was removed and the linked immunoaffinity support was washed 3
times in 50 ml of DMSO, then twice with 1N acetic acid, then washed with MilliQ H2O.
Finally, the support was stored in MilliQ H2O with 0.05% sodium azide at 4˚C until
further use.
To prepare the immunoaffinity support for use, most of the water was removed
and it was resuspended in 10X PBS and shaken by hand for 2 min.  The pH was checked
with test strips to ensure that it was near 7.  The 10X PBS was then removed and the
support was resuspended in 10 ml of 5X PBS.  All further steps were done at 4˚C unless
otherwise stated.  To prepare the preimmune and antisera for affinity purification, 10 ml
was thawed and Complete™ protease inhibitor cocktail (Roche) was added.  The serum
was then mixed with 10 ml of 10X PBS to bring it to a final concentration of 5X.  The
serum and support were mixed and allowed to incubate for 5 min then added to a glass
column.  The first flowthrough was collected and run through the column a second time.
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The column was then washed with 100 ml of 5X PBS in 10 ml fractions, which were
collected and measured for absorbance at 280 nM (A280) until absorbance decreased to
values similar to a blank.
Before antibody elution, 5X PBS was drained from the column until it reached
the top of the gel bed, then 5 ml of 100 mM NaCitrate pH 2.5 was added and allowed to
stand for 2 min before the column was reopened.  The eluant was collected in 1-1.5 ml
aliquots into siliconized Eppendorf tubes already containing 200 µL of 1M Tris pH 8.8.
Ten µl of normal goat serum (NGS) (Sigma) was then added to each tube, and the eluant
fractions were combined and dialyzed against 1 L of 1X PBS overnight at 4˚C in Slide-
A-Lyzer® dialysis cassettes (Pierce, Rockford, IL) with a 10,000 MW cutoff.  After the
sample was recovered, one tenth volume of 0.5% sodium azide was added and the
sample was concentrated down to 1.5 to 4 ml using a Centricon Plus-20 centrifugal filter
device (Millipore, Billerica, MA) with 100,000 MW cutoff.  Samples were stored at 4ºC
until use.
Functional assays with transfected CHO-K1 cells (CHO-BMLK3) were
performed as described in Chapter III, except that treated cells were incubated in
receptor antisera and preimmune sera for 4 hours at dilutions of 1:100 and 1:1000 in
normal growth medium prior to fluorophore loading and agonist challenge.
Immunocytochemistry
Approximately 10,000 CHO-BMLK3 or CHO-pcDNA cells were seeded on
glass slides using cytofuge concentrators (StatSpin Technologies, Norwood, MA) and
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allowed to grow for 48 h in growth medium and conditions as described in Chapter III.
Once cells reached 50-80% confluence, slides were cooled on ice and washed in 1X TBS
(25 mM Tris-HCl, 137 mM NaCl, 5 mM KCl, 0.6 mM Na2HPO4, 0.7 mM CaCl2, 0.5
mM MgCl2, pH 7.5).  Cells were fixed for 30 min in 2% paraformaldehyde solution at
4˚C, then washed 2x 5 min in cold TBS.  Cells were blocked in 2% normal goat serum
(Sigma) for 30 min at RT, then incubated in 1:500 dilutions of preimmune or receptor
antisera for 1 h at 4˚C.  Cells were then washed 5x 5 min in cold TBS and incubated in
20 µg/ml Texas Red Anti-rabbit IgG (Vector Laboratories Inc., Burlingame, CA) for 1 h
at 4˚C.  Cells were washed again 5x 5 min in cold TBS, then mounted with
Vectashield™ containing 4',6-Diamidino-2-phenylindole (DAPI) (Vector Laboratories
Inc.).  Microscopy was performed as previously described (Pietrantonio et al., 2001).
Western blots with CHO-BMLK3 cells and purified plasma membranes
For blots with complete cell lysate, cells were grown in T-75 tissue culture flasks
until monolayers reached confluence, then rinsed with PBS.  Cells were dislodged with a
rubber scraper into 3-5 ml of PBS per flask, then pelleted by centrifugation at 1000 xG
for 3 min.  Supernatant was discarded and cells were resuspended in SDS lysis buffer
(5% SDS, 10 mM NaCl, 0.1 mM EDTA, 10 mM Tris) for complete cell lysis or Nonidet
P-40 lysis buffer (1% Nonidet P-40, 50mM Tris, 150 mM NaCl), which does not
solubilize cell membranes.  Complete™ protease inhibitor cocktail (Roche) was added to
lysis buffers shortly before use.  Cell suspensions in lysis buffer were incubated at 37ºC
for 10 minutes then centrifuged at 15,000 x g for for 10 min to pellet nuclei and debris.
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The supernatant was retained and protein concentration was estimated by Bradford
assay.  From 20-40 µg of protein/lane from each sample and 10 µl of Rainbow
coloured protein molecular weight markers (Amersham, Buckinghamshire, UK) was
combined with an equal volume of 2X sample treatment buffer (0.125M Tris, 4% SDS,
20% glycerol, 0.1 mg/ml bromphenol blue, and 0.1M β-mercaptoethanol or 0.2M DTT)
and heated in boiling water for 3 min.  Samples and markers were loaded in a 10%
polyacrylamide SDS-Tris precast minigel (BioRad) under SDS running buffer (25 mM
Tris, 200 mM glycine, 0.1% SDS) and electrophoresed at 100 volts for 75-120 min.
A piece of Immobilon PVDF membrane (Millipore) was soaked briefly in
methanol then in transfer buffer (25mM Tris, 20mM glycine, 20% methanol) for 15 min.
After electrophoresis, the gel was recovered and soaked in transfer buffer for 15 min.
The gel and membrane were placed together between two pieces of Whatman 3M filter
paper and a sponge on each side, then loaded in the transfer apparatus.  The transfer
apparatus was placed on ice, and transfer was at 100V for 75 min.  After transfer, the
membrane was rinsed briefly with 0.1% PBS-Tween (PBST) and blocked overnight (16
h) in 10% Carnation® instant nonfat dry milk (Nestle, Solon, OH) dissolved in PBST at
RT with gentle agitation.  The blot was washed briefly to remove blocking solution and
incubated in primary antibody at various dilutions for 3 h at RT, then washed 5x10 min
in PBST.  The blot was then incubated in a 1:20,000 dilution of goat-antirabbit
horseradish peroxidase conjugated antibody (Molecular Probes) for 1 h at RT, and
washed 5x10 min in PBST.  For detection, the blot was incubated in a 1:1 mixture of
SuperSignal® West Pico Stable Peroxide Solution and SuperSignal® Luminol/Enhancer
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Solution (Pierce) for 5 min, then placed between two pieces of Saran wrap and exposed
to film (Fuji medical x-ray film, Fuji Photo Film Co., Tokyo, Japan).
For westerns using preabsorbed antisera, anti-receptor antisera (1:1000 dilution
in 10 ml PBST with Complete protease inhibitor cocktail, Roche) were preabsorbed with
either 500 µg of antigen-peptide or on a monolayer of prewashed CHO-pcDNA cells in a
T-25 tissue culture flask for 7 h at RT with gentle agitation.
Purification of cell plasma membranes
Methods used for subcellular fractionation of cells by differential centrifugation
in order to purify plasma membranes were adapted from protocols by Haga & Berstein
(1997) and Graham & Higgins (1993).  Cell monolayers from four T-75 tissue culture
flasks were rinsed with ice cold homogenizing buffer (20 mM HEPES, 10 mM EDTA,
protease inhibitor cocktail, pH 7.4), then dislodged with a rubber scraper into 4 ml of
homogenizing buffer.  Cell suspensions were centrifuged for 2 minutes at 1,000 RPM,
and cell pellets were combined and resuspended in 3 ml of homogenizing buffer.  Cells
were homogenized for 30 strokes with a glass homogenizer, then sonicated for 10-15
seconds at power level 5 on a Fisher Scientific 50 sonic dismembranator.  Homogenized
samples were then centrifuged in several steps: 1) 10 min at 3,000 x g, 2) 10 min at
10,000 x g, 3) 20 min at 20,000 x g, and 4) 2 hours at 100,000 x g.  After each
centrifugation step the pellet was retained and the supernatant was subjected to further
centrifugation.  The final supernatant was retained as fraction 5.  Each fraction was then
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resuspended in 100 µl SDS lysis buffer, and protein concentration was estimated by
Bradford assay.
RT-PCR
Five partially engorged female ticks were dissected under sterile PBS and guts,
salivary gland, Malpighian tubules, synganglia, ovaries, and salivary glands were
removed whole or in pieces and place directly into RNAlater solution (Ambion) and
stored at -20°C.  Poly-A+ RNA was extracted from the tissues using an mRNA Direct
kit (Dynal), and eluted at 80°C in water containing RNAsecure solution (Ambion).  First
strand cDNA was synthesized from one half of the Poly-A+ RNA at 42°C for 50 min
with oligo(dT)12-18 primer using Superscript II Reverse transcriptase (Superscript
Preamplification System, Life Technologies).  PCR amplification of receptor cDNA was
performed using two separate sets of gene specific primers, 1F (5’-AGT TCA TCA TCT
GCG GTA TCT GGA C) and 4R (5’-GTA CAC GAA ACA GAT GGT GAG CAG C),
and SC1-F (5’-TTC CGC TAT GGT GCC ACA ATG A) and SC3-R (5’-TGG TGG
TTG GAC TCA AAT TAC AC).  Amplification of β-actin cDNA with primers Act-3F
(5’-TCC TCG TCC CTG GAG AAG TCG TAC) and Act-4R (5’-CCA CCG ATC CAG
ACC GAG TAC TTC) was also done as a positive control to show that sufficient
quantity and quality of cDNA was present in each sample.  Reactions contained
synthesized cDNA approximately equivalent to the specific tissue from one half of a
tick, 200 µM each of four dNTPs, 0.2 µM of each primer, 0.5 µl Advantage 2
polymerase mix and 5 µl 10X reaction buffer (ClonTech) in a final volume of 50 µl.
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The following cycling parameters were used: 94°C for 1 min followed by 40 cycles of
94°C for 20 sec, 65°C for 30 sec, and 68°C for 45 sec.  Final extension was at 68°C for 5
min.  Products were electrophoresed on a 10% agarose-TBE gel containing ethidium
bromide and photographed.
Results
In order to determine the presence of receptor transcript in specific tick tissues,
cDNA was synthesized separately from dissected ovaries, synganglion, gut, salivary
glands, and Malpighian tubules from partially engorged adult females.  RT-PCR
experiments to detect the presence of receptor transcript in specific tick tissues were
repeated with two separate primer pairs to ensure that no false results could arise from
PCR artifacts.  Primer set 1 (1F & 4R) (Fig. 9B), and primer set 2 (SC1-F & SC3-R)
(Fig. 9C) gave similar results.  Amplified receptor cDNA bands of the expected sizes
(330, 211, and 708 bp for Fig. 9A, B, C respectively) were visible in the corresponding
lanes for each tissue tested.  Although the PCR was not done in a quantitative manner,
the band in the Malpighian tubule lane clearly contained the least amplified cDNA of all
the samples while the corresponding control amplification of β-actin transcript was fairly
high (Fig. 9A).  These results likely indicate a low amount of receptor transcript in the
Malpighian tubule relative to other tissues.
Antisera against the synthetic peptide RVETQVESHALNLTKC linked to
keyhole limpet hemocyanin (KLH) was raised in two rabbits.  The third production
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bleed from rabbit GN-2489 had the highest antibody titer, which was 1:100,000 as
determined by ELISA (Sigma Genosys), and was used in all further experiments.  The
synthetic peptide sequence corresponds to the N-terminal portion of the second
extracellular loop, and was chosen because of its expected extracellular presentation,
possible involvement in ligand-binding, and its predicted high antigenicity (Fig. 10).
Other areas of the receptor with high antigenicity were intracellular, with the exception
of the N-terminus.
In order to test if binding of receptors by antibody might have a blocking or other
effect on live cells, CHO-BMLK3 cells were exposed to 100 nM of the peptide
FFFSWG-NH2 after preincubation in media containing no additional sera, preimmune
sera, or receptor antisera.  Cells were incubated for four hours in antisera concentrations
of 1:1000 and 1:100.  None of the treatments had an observable effect on the
intracellular calcium response (Fig. 11, only data for 1:100 concentrations shown).  This
lack of an effect from the antisera seemed to indicate that there were not enough
antibodies specifically binding the tick myokinin receptor for it to be useful, although
this result does not eliminate the possibility that antibodies were binding to the receptor
without interfering with its function.
Additional experiments were conducted to determine if this antisera would
interact specifically enough with the receptor to be useful for further immunolocalization
studies in ticks.  Immunocytochemistry was done with CHO-BMLK3 cells to see if the
antisera could label plasma membranes expressing the receptor.  Receptor antisera did
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Figure 9.  RT-PCR with isolated tick tissues.  A) Control PCR with primers against β-
actin shows presence of cDNA from each tissue sample. B) PCR with gene specific
primers for tick kinin receptor 1F & 4R .  C) PCR with gene specific primers (SC1-F &
3R) shows similar results to B).  M = marker; (+) = positive control cDNA (Superscript
preamplification system, Life Technologies); OV = ovary; Syn = synganglion; Sg =
salivary gland; MT = Malpighian tubule.
β-actin
A)  M    OV   Syn  Gut    Sg   MT
Receptor
 M      (+)   OV   Syn  Gut    Sg   MT   MB)
 M     (+)  OV   Syn Gut  Sg    MT    M
Receptor
C)
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Figure 10.  Kyte and Doolittle hydrophilicity plot and Jameson antigenic
index of the tick myokinin receptor.  Antisera was directed aginst the
portion of the receptor labeled EC2.  The figure was created with
DNASTAR software (DNASTAR, Inc., Madison, WI).  IC1 =
intracellular loop 1,  IC2 = intracellular loop2, EC2 = extracellular loop
2, IC3 = intracellular loop 3.
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not generate any signal in plasma membranes above the background level observed in
cells treated with preimmune sera (data not shown).
Figure 11.  Response of CHO-BMLK3 cells to 100 nM FFFSWG-NH2 following pretreatment
with antisera.  Control was addition of media with no peptide.  The other traces represent a
normal response with no pretreatment, and pretreatment for 4 h with 1:100 dilution of sera from
preimmune and postimmune bleeds, respectively.
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Several western blots were done in order to determine if the antisera contained
antibodies that would recognize the denatured protein on a membrane.  The receptor
band was expected to be at 44.9 kDa or higher, based on its predicted molecular mass
(Chapter II) and the possibility of glycosylation.  The western blot technique is
considered more sensitive than immunohistochemistry or immunocytochemistry.
Protein lysates from both whole cells and purified plasma membranes of CHO-BMLK3
cells were used.
Western blots using entire cells prepared in Nonidet P-40 lysis buffer did not
reveal any bands specific to the CHO-BMLK3 cells that were also present in the
negative control cell line CHO-pcDNA (vector transfected only), although there was
more unspecific signal in the receptor antisera blot than the preimmune blot (Fig. 12).
Additionally, preabsorption of antibodies with the synthetic peptide
RVETQVESHALNLTKC, did not result in the observable loss of any bands in the
preabsorbed antisera in comparison with untreated antisera.  Preabsorption of antisera
with the negative control cell line did result in the loss of at least one background band
approximately 70 kDa in size (Fig. 13).
Use of affinity purified antisera in western blots reduced much of the unspecific
binding seen.  Some bands were visible in these blots, but none were seen in the
transfected cells that were not seen in the control lanes (Fig. 14).
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Figure 12.  Western blot of CHO-BMLK3 and CHO-pcDNA cells with complete
preimmune and anti-receptor antisera.  Protein lysate was prepared in Nonidet P-40
buffer.  Primary antibody concentration was 1:1000.  M = marker, 40P = 40 µg total
protein from CHO-pcDNA, 20 = 20 µg total protein from CHO-BMLK3, 40 = 40 µg
total protein from CHO-BMLK3.
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Figure 13.  Western blot of CHO-BMLK3 cells with preabsorbed complete anti-receptor
antisera.  Protein lysate was prepared in Nonidet P-40 buffer.  Primary antibody
concentration was 1:1000.  In anti-receptor lanes, antibodies were not preabsorbed.
Peptide preabsorbed and CHO-K1 were preabsorbed for 7 h at RT in the presence of 50
µg/ml of peptide or intact untransfected CHO-K1 cells, respectively.  M = marker, 20 =
20 µg total protein, 40 = 40 µg total protein.
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In order to further reduce background interference and enhance any possible
signal from specific bands, subcellular fractionation of CHO-BMLK3 and control cell
lines was done by differential centrifugation to purify plasma membranes.  A
commercially prepared rabbit anti-integrin β5 subunit polyclonal antibody was used as a
marker for the presence of membrane protein.  This antibody labels a protein 100 kDa in
size in humans (Ramaswamy & Hemler, 1990), although the expected size in CHO-K1
cells is not known.  In our Western blots using this antibody against subcellular fractions
it labeled a protein approximately 70 kDa in size (Fig. 15).  This band appeared to be
Preimmune
 B1     C       B2     M
Anti-receptor
 B1     C       B2
45
66
97
Figure 14.  Western blot of CHO-BMLK3 and CHO-pcDNA cells with affinity
purified preimmune and anti-receptor antisera.  Primary antibody concentration was
1:50.  M = marker, B1 = 200 µg total protein from CHO-BMLK3 (Nonidet P-40
lysate), C = 40 µg total protein from CHO-pcDNA (SDS lysate), B2 = 40 µg total
protein from CHO-BMLK3 (SDS lysate).
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most purified in fraction #5 (the final supernatant) rather than in fraction #4 as expected
(pelleted membranes and ribosomal material).  Because of this discrepancy from the
expected result, both fractions 4 and 5 were used in further Westerns using affinity
purified receptor antisera.  However, the use of affinity purified antisera and subcellular
fractions did not result in the specific labeling of any protein bands in comparison to
negative controls (Fig. 16).
In summary, no experiments conducted with rabbit anti-
RVETQVESHALNLTKC peptide antisera produced any evidence for the presence of
antibodies that would specifically label the tick receptor.
  M    1     2    3     4      5     M
97
66
45
Figure 15.  Western blot of subcellular fractions of CHO-BMLK3 cells with rabbit
anti-integrin β5 subunit polyclonal antibody.  Primary antibody concentration was
1:10,000.  M = marker, 1-5 indicates fractions 1-5 respectively.  Each sample lane
contained 20 µg of total protein.
104
Figure 16.  Western blot of subcellular fractions 4 & 5 of CHO-BMLK3 cells with affinity
purified antireceptor antisera.  Primary antibody concentration was 1:50.  M = marker, 4 & 5
indicate fractions 4 & 5, respectively.  Each sample lane contained 20 µg of total protein.  A)
Secondary antibody used was 1:20,000 dilution of goat-antirabbit horseradish peroxidase
conjugated antibody (Molecular Probes). B) This blot was a replicate of the blot shown in A,
except that the secondary antibody was used at 1:10,000 dilution.
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Discussion
The presence of tick receptor transcript in multiple tissues most likely indicates
that the myokinins have multiple or higher functions in ticks.  Although the only
established functions of myokins are limited to the insect hindgut and Malpighian
tubules, it is not unexpected that the myokinins would also have functions in the brain or
CNS of arthropods.  It has previously been suggested that due to the distribution of
leucokinin immunoreactive neurons, roles for myokinins as neuromodulators or
neurotransmitters are possible in certain parts of the brain, visual system, and ventral
ganglia of insects.  Additionally, roles for myokinins in regulating feeding, heart
function, and respiration have been suggested (Nässel et al., 1992; Nässel, 2002).  This
first suggestion has been supported by a study showing that injection of Heliothis
virescens larvae with myokinin peptides causes a significant reduction in weight gain
(Seinsche et al., 2000).  Similarly, injection of another neuropeptide, sulfakinin, has
been shown to significantly inhibit food uptake in nymphs of the desert locust,
Schistocerca gregaria (Wei et al., 2000).
Our finding that tick receptor transcript is present in the gut, synganglion, and
Malpighian tubules of adult females was not unexpected due to similar results from other
arthropods which have already been discussed.  By analogy with insects, it is most likely
that the tick myokinin receptor stimulates excretion in the digestive system (gut and
Malpighian tubules), although this possibility has not been tested.  It is possible that the
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tick myokinin receptor has some function in the CNS, however there is as of yet no
experimental data on this subject.
The tick myokinin receptor appears to be transcribed throughout all the life
stages and in multiple tissues of the tick.  The presence of the tick receptor transcript in
the ovaries and salivary glands is similar to evidence of myokinin receptors or myokinin
function that has only recently been demonstrated in D. melanogaster gonads (Radford
et al., 2002) and Rhodnius salivary glands (Orchard & Te Brugge, 2002).  The
drosokinin receptor transcript has been detected in multiple tissues including both the
male and female gonads, leading to speculation that myokinins may be important in
fertility or the peristaltic transfer of sperm or eggs (Radford et al., 2002).  It is equally
possible that myokinins may effect fertility or egg transfer in ticks, however there are
currently no experimental results to back up such speculation .
During blood feeding in the hard ticks, the salivary glands become more
significant in maintaining osmotic balance and expelling excess water from the
bloodmeal back into the host.  Additionally, in blood feeding arthropods such as ticks
and mosquitos the salivary glands are a key organ in the transmission of pathogens.
Myokinins have an important role in regulating diuresis in insects, and if they have a
simlar role in ticks it may be through regulation of salivary gland function.  In insects, it
has been demonstrated that in the blood-feeding bug R. prolixus, leucokinin I and a
CRF-related peptide induce a dose-dependent increase in the basal tonus and phasic
contractions of the salivary glands (Orchard & Te Brugge, 2002).  Myokinins do not
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seem to have a direct effect on Rhodnius Malpighian tubules (Te Brugge et al., 2001),
although they may increase hindgut contractions.
The possibility of myokinin regulation of function in the ovaries or salivary
glands suggests that the tick myokinin receptor may indeed be an excellent target for
novel acaricide development or protective vaccines.  Perturbation of either of these
critical functions could prove quite detrimental to tick populations, either through
reduction in fertility or interference with normal feeding behavior.  In addition to
interfering with feeding, targeting a receptor in the salivary glands may also impact the
vector competence of blood feeding arthropods, which may be an equally viable strategy
to eradication for breaking the disease transmission cycle.
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CHAPTER V
CONCLUSIONS
This dissertation provides significant novel contributions to the fields of tick
physiology and myokinin signal transduction in arthropods.
The characterization of the B. microplus myokinin receptor cDNA described in
this dissertation represents the cloning and identification of the first neuropeptide
receptor from the Acari, as well as the first functional expression of a GPCR from the
Acari.  Additionally, the B. microplus receptor is the second G-protein coupled receptor
(GPCR) known from any tick species.
The B. microplus receptor was the first myokinin receptor to be cloned from an
arthropod, and is the second known member of the myokinin receptor subfamily after
the lymnokinin receptor from the pond snail.  While our report on the functional
expression of the B. microplus receptor was in press (Holmes et al., 2003), a report on
the functional expression of the drosokinin receptor was published online ahead of ours
(Radford et al., 2002).  Thus, these two receptors became the first to be unequivocally
identified as myokinin receptors from arthropods, and the first myokinin receptors to be
functionally expressed from insects and ticks, respectively.
Evidence of the transcriptional expression of this receptor by RT-PCR
experiments constitutes the first evidence of myokinin regulated signal transduction in
the Acari.  Based on the sequence similarity of the B. microplus receptor to gene product
CG10626 in the D. melanogaster genome (Adams et al., 2000), we were able to
109
correctly predict that this gene product was the Drosophila myokinin (drosokinin)
receptor (Holmes et al., 2000; Radford et al., 2002).
When expressed in mammalian cells, the B. microplus receptor was activated by
myokinin peptides at nanomolar concentrations, including the naturally occurring
lymnokinin and muscakinin peptides as well as several designed myokinin analogs.
Analysis of signal transduction in these cells showed that the peptide-agonist induced
calcium response originated from intracellular calcium stores, most likely resulting from
activation of pertussis toxin insensitive Gαq proteins.  Expression of the B. microplus
receptor in CHO-K1 cells makes available a system for screening compounds for agonist
or antagonist activity, which has already been used for testing hypotheses of receptor-
agonist interactions, and may be useful for identifying compounds with acaricidal
activity.
The detection of receptor transcripts by RT-PCR in the dissected synganglion,
gut, salivary glands, ovaries, and Malpighian tubules of partially engorged adult female
ticks is the first indication of myokinin receptor expression in specific tick tissues.  The
distribution of myokinin receptor expression in the tick was more extensive than what
we expected from what is known in insects.  Until recently, myokinin function had only
been demonstrated in the insect digestive system, and was suggested in insect brain and
nervous system based on the high incidence of neurons with leucokinin-like
immunoreactivity (Nässel, 1996; Nässel, 2002).  Our report is the first evidence of
myokinin receptor expression in the tissues of an arachnid outside of the nervous system.
Consistent with our findings in the tick, evidence for myokinin receptor expression has
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also been found in the reproductive organs of Drosophila (Radford et al., 2002) and a
myokinin-induced response has been demonstrated in the salivary glands of the blood-
feeding bug Rhodnius prolixus (Orchard & Te Brugge, 2002).  These new target tissues
for myokinins support the possibility of multi-functional and complex signaling
interactions in this peptide family.
The tick myokinin receptor responds to myokinin agonists, and appears to be
present in multiple tissues, but no function in any tissue has been established.  In
Drosophila, the endogenous ligand of the drosokinin receptor and its function in the
Malpighian tubules are known only due to research done prior to the identification of the
receptor (Radford et al., 2002).
Receptor localization in specific tissues is a critical first step for developing
hypotheses regarding receptor function.  Although the receptor transcript has been
detected in multiple tick tissues, attempts to use specific antibodies in western blots or
immunohistochemistry to unequivocally demonstrate the expression of the receptor
protein were not successful.  Development of a receptor antiserum that specifically binds
a receptor antigen is critical for this effort.
In addition to immunolocalization, antireceptor antibodies could be used to
identify functionally important regions of the receptor.  For example, antibodies that
block the agonist activated response or induce activity by themselves may identify the
ligand binding domain(s) of the receptor.  This knowledge could potentially be used to
aid in the modeling and prediction of synthetic non-peptide agonists potentially useful as
novel acaricides.  Additionally, the identification of immunogenic antigens from the
111
receptor is a critical first step for the development of a vaccination strategy.  Vaccination
of cattle with “hidden”antigens, or those not normally presented to the immune system
during the course of normal feeding, has already been demonstrated to be a valid control
strategy for B. microplus.  Inoculation of cattle with the tick gut antigen Bm86 gives
cattle a protective response that is most effective against tick larvae (Willadsen et al.,
1995).  If the tick myokinin receptor is present in salivary glands and the gut or
associated muscles as predicted by RT-PCR results, host antibodies should have no
trouble finding receptors to act on.  Active antibodies from vertebrate hosts have been
detected in the hemolymph of both B. microplus and the lone star tick Amblyomma
americanum (Vaz et al., 1996; Jasinskas et al., 2000), so theoretically antibodies could
interact with any target tissue in the tick.
 The work reported in this dissertation includes the first evidence of myokinin-
like signal transduction in ticks, and not suprisingly there is much basic information that
remains unknown.  Because we have shown that myokinin agonists induce the release of
intracellular calcium in transfected cells, we have assumed that this second messenger is
the result of IP3 production by phospholipase C following activation by Gαq.  This is the
most likely explanation, however this could be confirmed by testing receptor transfected
cells for an agonist induced IP3 response.
The nature of the endogenous ligand(s) of the tick myokinin receptor remains a
critical and unanswered question.  There is a possibility of additional myokinin receptors
in the tick, and if they are present this would not be unexpected given the
multifunctional nature of the myokinins in invertebrates.  Currently it appears that there
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is only a single myokinin receptor in the Drosophila and Anopheles gambiae genomes
(Radford et al., 2002; Hill et al., 2002), and only single receptors have been isolated
from L. stagnalis and B. microplus respectively (Cox et al., 1997), (Holmes et al., 2000).
However, different responses to the three leucokinin peptides seen in the Malpighian
tubule of the mosquito Aedes aegypti (Veenstra et al., 1997) may indicate two or more
myokinin receptors in this species.  Because we expressed the B. microplus receptor in a
heterologous system (CHO-K1 cells), it is also possible that the receptor may have
different post-translational modifications in the tick than in our system, perhaps resulting
in an altered response or pharmacological profile.
Unfortunately, no candidate myokinin-like peptides have been isolated from any
tick.  Clearly, the tick receptor responded specifically to peptides with the conserved C-
terminal pentapeptide motif (FXXSWG-NH2; see Chapter III) that defines the insect
myokinins peptide family with the only exception that the Gly residue could be replaced
with a Ser.  Beyond the presence of this motif, it is difficult to speculate on the nature of
an endogenous ligand with the data generated in this study.  Endogenous ligands do not
necessarily give the strongest response in functional assays in comparison to other
synthetic agonists.  Also there is a strong possibility that the tick has multiple
endogenous ligands.  Among insects from which myokinins have been isolated, only in
the higher Diptera (Musca domestica and D. melanogaster) and in the locust Locusta
migratoria have single ligands been found (Holman et al., 1999; Terhzaz et al., 1999).
In other insects, from 3 to 8 myokinins have been isolated, including the mosquitoes
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Aedes aegypti and Culex salinarius, which each have 3 peptides respectively (see
Pietrantonio et al. 2000, Table 1).
Any discussion of myokinins and their potential functions of ticks must largely
rely on analogy with insects, because knowledge of tick neuropeptides is non-existent
and on GPCRs is extremely limited.  No neuropeptides have been isolated from ticks,
and only three tick GPCRs of any type have been described, all from B. microplus
(Baxter & Barker, 1999; Holmes et al., 2000; Chen et al., 2003).  Because the myokinins
are widely distributed and conserved among invertebrate groups, our working hypothesis
is that what is known in other arthropods (insects) will also hold true in ticks.  In insects,
myokinin-like immunoreactivity has been found in both neurosecretory cells and in
interneurons (see Nässel 2002 for review) indicating function as both neurotransmitters
or neuromodulators and as neurohormones.  Although some insects have abdominal
neurosecretory cells which are immunoreactive for myokinins, no innervation with
myokinin-like immunoreactivity has been detected in Malpighian tubules or hindguts,
except in the gut of R. prolixus (Te Brugge et al., 2001; Nässel, 2002).  The myokinins
are almost certainly released into the hemolymph and act as neurohormones on target
tissues such as the Malpighian tubules, hindgut, and other tissues that putatively express
myokinin receptors.
This multifunctional aspect of the myokinins is most likely indicative of their
involvement in many complex interactions, which may complicate studies involving
whole organisms.  However, this is not unexpected because peptide hormones in insects
are generally master regulators and affect a number of physiological processes (Keeley
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& Hayes, 1987).  The multiple functions of myokinins and their receptors may make
them attractive as targets for novel acaricides.  Precedence for this approach has been set
by the formamidines, a successful class of insecticides/acaricides that target the
octopamine receptor.  Although not a neuropeptide, the biogenic amine octopamine
functions as a neurotransmitter, neuromodulator, and neurohormone in insects by acting
through a GPCR in target tissues.  The formamidines are receptor agonists that cause
anorexia and death in insects (Ismail & Matsumura, 1991).
Further experiments are needed order to validate the myokinin receptor as a
target for novel control strategies against the tick.  One conceivable control strategy is
the development of compounds that act as receptor agonists or antagonists.  Although no
insect or tick neuropeptide mimetics have been developed that have sufficient
environmental persistence to be useful as pesticides, the transfected cell line CHO-
BMLK3 or similar expression systems could easily be developed to screen candidate
compounds for receptor activity.  The most difficult aspect of this approach may be
synthesizing compounds that have the required properties of peptide agonists but that are
not easily degraded.
As molecular insect science moves into the post-genomic era, the now labor
intensive efforts needed to clone genes by homology screening of libraries or degenerate
RT-PCR will be facilitated by the information present in various insect genomes.
GPCRs are notoriously difficult to characterize using classical molecular methods, and
already the genomic information available from insects has made a large impact in this
field.  The genomes of the fruit fly D. melanogaster and the malaria mosquito Anopheles
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gambiae have been completely sequenced (Adams et al., 2000), (Holt et al., 2002), and
the sequence of the honey bee Apis mellifera genome is expected to be complete in
December 2003 (http://www.hgsc.bcm.tmc.edu/projects/honeybee/).  With the large
sequencing capacity now available, genome projects of other economically important
arthropods are sure to follow.
There are currently 30 identified genes that encode predicted neuropeptides and
insulin-like peptides in Drosophila (Nässel, 2002).  Additionally, about 200 GPCRs
have been predicted (Brody & Cravchik, 2000), 44 of which are peptide receptors
(Hewes & Taghert, 2001).  Analysis of the malaria mosquito Anopheles gambiae
genome has predicted 25 Class A peptide receptors, out of a total of 276 GPCRs (Hill et
al., 2002) and identified the genes of 35 putative regulatory peptides (hormones and
neuropeptides) (Riehle et al., 2002).  Already the genomic information available has led
to the expression and further characterization of multiple GPCRs.  Based on information
from the Drosophila genome, a novel family of over 100 genes that likely represent
odorant receptors has been discovered (Vosshall et al., 1999).  Additionally, the first
insect receptors for myokinin, ecdysis triggering hormone, FMRFamide, and proctolin
were intitially predicted based on genomic information, then expressed and characterized
(Holmes et al., 2000; Radford et al., 2002; Iversen et al., 2002; Cazzamali &
Grimmelikhuijzen, 2002; Johnson et al., 2003; Egrod et al., 2003).
The explosion of genomic information means that there will be more work to do
in insect molecular science, not less.  Although computer programs used for
bioinformatics are very useful tools, they do not evaluate results within a biological
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context or apply common sense, and are known to make errors.  Additionally, the
identification of a gene is just the first step that must be taken in the characterization of
its final product and the role of that product in the cell, tissue, and whole organism.  In
some sense, genomics can be considered simply as a shortcut past the first step in
molecular biology after which the hard work begins.
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